window.__IS_SSR__=true
window.__INITIAL_STATE__={
"attachmentsReducer": {
"audio_0": {
"type": "attachments",
"id": "audio_0",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background0.jpg"
}
}
},
"audio_1": {
"type": "attachments",
"id": "audio_1",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background1.jpg"
}
}
},
"audio_2": {
"type": "attachments",
"id": "audio_2",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background2.jpg"
}
}
},
"audio_3": {
"type": "attachments",
"id": "audio_3",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background3.jpg"
}
}
},
"audio_4": {
"type": "attachments",
"id": "audio_4",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background4.jpg"
}
}
},
"placeholder": {
"type": "attachments",
"id": "placeholder",
"imgSizes": {
"thumbnail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-160x107.jpg",
"width": 160,
"height": 107,
"mimeType": "image/jpeg"
},
"medium": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-800x533.jpg",
"width": 800,
"height": 533,
"mimeType": "image/jpeg"
},
"medium_large": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-768x512.jpg",
"width": 768,
"height": 512,
"mimeType": "image/jpeg"
},
"large": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"1536x1536": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1536x1024.jpg",
"width": 1536,
"height": 1024,
"mimeType": "image/jpeg"
},
"fd-lrg": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1536x1024.jpg",
"width": 1536,
"height": 1024,
"mimeType": "image/jpeg"
},
"fd-med": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"fd-sm": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-800x533.jpg",
"width": 800,
"height": 533,
"mimeType": "image/jpeg"
},
"post-thumbnail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"twentyfourteen-full-width": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1038x576.jpg",
"width": 1038,
"height": 576,
"mimeType": "image/jpeg"
},
"xxsmall": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-160x107.jpg",
"width": 160,
"height": 107,
"mimeType": "image/jpeg"
},
"xsmall": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"small": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"xlarge": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"full-width": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1920x1280.jpg",
"width": 1920,
"height": 1280,
"mimeType": "image/jpeg"
},
"guest-author-32": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 32,
"height": 32,
"mimeType": "image/jpeg"
},
"guest-author-50": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 50,
"height": 50,
"mimeType": "image/jpeg"
},
"guest-author-64": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 64,
"height": 64,
"mimeType": "image/jpeg"
},
"guest-author-96": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 96,
"height": 96,
"mimeType": "image/jpeg"
},
"guest-author-128": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 128,
"height": 128,
"mimeType": "image/jpeg"
},
"detail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 160,
"height": 160,
"mimeType": "image/jpeg"
},
"kqedFullSize": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1.jpg",
"width": 2000,
"height": 1333
}
}
},
"futureofyou_2707": {
"type": "attachments",
"id": "futureofyou_2707",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "2707",
"found": true
},
"parent": 2703,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-400x268.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 268
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-960x643.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 643
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2.jpg",
"width": 2556,
"height": 1711
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-1180x790.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 790
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-800x536.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 536
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-1180x790.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 790
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-75x75.jpg",
"width": 75,
"mimeType": "image/jpeg",
"height": 75
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/womens-health-2-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1430775907,
"modified": 1430775959,
"caption": "Women running a race to support cancer research ",
"description": null,
"title": "women's health 2",
"credit": " Alan Weir / Flickr",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_2987": {
"type": "attachments",
"id": "futureofyou_2987",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "2987",
"found": true
},
"parent": 2981,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-400x266.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 266
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-960x639.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 639
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson.jpg",
"width": 4000,
"height": 2664
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-1180x786.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 786
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-1180x786.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 786
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-75x75.jpg",
"width": 75,
"mimeType": "image/jpeg",
"height": 75
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/krista-donaldson-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1431475969,
"modified": 1431476034,
"caption": "D-Rev CEO Krista Donaldson interviews a doctor in the field ",
"description": null,
"title": "krista donaldson",
"credit": "D-Rev",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_2856": {
"type": "attachments",
"id": "futureofyou_2856",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "2856",
"found": true
},
"parent": 2853,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-400x300.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 300
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-960x720.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 720
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA.jpg",
"width": 3072,
"height": 2304
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-1180x885.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 885
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-800x600.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 600
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-1180x885.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 885
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-75x75.jpg",
"width": 75,
"mimeType": "image/jpeg",
"height": 75
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/05/DNA-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1431103928,
"modified": 1431103970,
"caption": "A molecule display at the Oxford University Natural History Museum",
"description": null,
"title": "DNA",
"credit": "net_efekt / Flickr ",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_843": {
"type": "attachments",
"id": "futureofyou_843",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "843",
"found": true
},
"parent": 839,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-400x225.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 225
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-320x180.jpg",
"width": 320,
"mimeType": "image/jpeg",
"height": 180
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59.jpg",
"width": 2200,
"height": 1237
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-1180x663.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 663
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-800x450.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 450
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-1180x663.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 663
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-768x432.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 432
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-75x75.jpg",
"width": 75,
"mimeType": "image/jpeg",
"height": 75
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2015/03/color-blindness-1_wide-bf5c91a846f6e9f0fa01df588c4d6a1f59731e59-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1427391076,
"modified": 1427391545,
"caption": "A simulation from the Neitz lab of what colorblindness looks like, with normal color vision on the left and red-green colorblindness on the right.\n(Courtesy Neitz Laboratory)",
"description": "A simulation from the Neitz lab of what colorblindness looks like, with normal color vision on the left and red-green colorblindness on the right.",
"title": "A simulation from the Neitz lab of what colorblindness looks like, with normal color vision on the left and red-green colorblindness on the right.",
"credit": null,
"status": "inherit",
"isLoading": false,
"fetchFailed": false
}
},
"audioPlayerReducer": {
"postId": "stream_live",
"isPaused": true,
"isPlaying": false,
"pfsActive": false,
"pledgeModalIsOpen": true,
"playerDrawerIsOpen": false,
"liveAudioPlayStartedAt": 0,
"liveAudioPlayContext": ""
},
"authorsReducer": {
"2718": {
"type": "authors",
"id": "2718",
"meta": {
"override": true
},
"slug": "2718",
"name": "Gabrielle Guthrie",
"firstName": "Gabrielle",
"lastName": "Guthrie",
"bio": "Gabrielle Guthrie has a Masters in Design from Stanford University. She is co-founder of the women-centered design start up, Moxxly. She lives and works in San Francisco.",
"email": "gabrielle@moxxly.com",
"isLoading": false
},
"byline_futureofyou_2853": {
"type": "authors",
"id": "byline_futureofyou_2853",
"meta": {
"override": true
},
"slug": "byline_futureofyou_2853",
"name": "Rob Stein",
"isLoading": false
},
"byline_futureofyou_839": {
"type": "authors",
"id": "byline_futureofyou_839",
"meta": {
"override": true
},
"slug": "byline_futureofyou_839",
"name": "Jon Hamilton",
"isLoading": false
},
"cfarr": {
"type": "authors",
"id": "3252",
"meta": {
"index": "authors_1716337520",
"id": "3252",
"found": true
},
"name": "Christina Farr",
"firstName": "Christina",
"lastName": "Farr",
"slug": "cfarr",
"email": "cfarr@kqed.org",
"display_author_email": false,
"staff_mastheads": [],
"title": "KQED Contributor",
"bio": "Christina Farr (\u003ca href=\"https://twitter.com/chrissyfarr\">@chrissyfarr\u003c/a>) is the former editor and host of Future of You. She was previously with Reuters, covering digital health and Apple and before that, she reported for Venture Beat. Christina was born and raised in London and has graduate degrees from University of London and the Stanford School of Journalism. Farr’s work has appeared in a variety of publications, including the New York Times, the Daily Telegraph, the Bay Citizen and SFGate.com. She has appeared as a featured expert on NBC, ABC and Reuters TV, among others, and frequently speaks at health and technology conferences. She is also co-founder of Ladies Who Vino, a networking group for women in technology and business.",
"avatar": "https://secure.gravatar.com/avatar/22c63869a7901c61c15e204391c1261d?s=600&d=blank&r=g",
"twitter": null,
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "futureofyou",
"roles": [
"administrator"
]
},
{
"site": "stateofhealth",
"roles": [
"author"
]
},
{
"site": "science",
"roles": []
}
],
"headData": {
"title": "Christina Farr | KQED",
"description": "KQED Contributor",
"ogImgSrc": "https://secure.gravatar.com/avatar/22c63869a7901c61c15e204391c1261d?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/22c63869a7901c61c15e204391c1261d?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/cfarr"
}
},
"pagesReducer": {
"futureofyou_category_hopehype": {
"type": "terms",
"id": "futureofyou_1062",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1062",
"score": 13.892755
},
"featImg": null,
"name": "Hope/Hype",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Hope/Hype Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1062,
"slug": "hopehype",
"isLoading": false,
"title": "Hope/Hype",
"pageMeta": {
"site": "futureofyou",
"WpPageTemplate": "page-topic-editorial",
"currentPage": 25
},
"blocks": [
{
"blockName": "kqed/post-list",
"attrs": {
"layout": "cardArticle2",
"query": "posts/futureofyou?category=hopehype",
"seeMore": false,
"paginated": true,
"page": 25
}
},
{
"blockName": "kqed/ad"
}
]
}
},
"pfsSessionReducer": {},
"postsReducer": {
"stream_live": {
"type": "live",
"id": "stream_live",
"audioUrl": "https://streams.kqed.org/kqedradio",
"title": "Live Stream",
"excerpt": "Live Stream information currently unavailable.",
"link": "/radio",
"featImg": "",
"label": {
"name": "KQED Live",
"link": "/"
}
},
"stream_kqedNewscast": {
"type": "posts",
"id": "stream_kqedNewscast",
"audioUrl": "https://www.kqed.org/.stream/anon/radio/RDnews/newscast.mp3?_=1",
"title": "KQED Newscast",
"featImg": "",
"label": {
"name": "88.5 FM",
"link": "/"
}
},
"futureofyou_2703": {
"type": "posts",
"id": "futureofyou_2703",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "2703",
"score": null,
"sort": [
1431710107000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou",
"term": 219
},
"blocks": [],
"publishDate": 1431710107,
"format": "standard",
"disqusTitle": "Women's Health is Too Often Overlooked; Will Digital Health be the Exception?",
"title": "Women's Health is Too Often Overlooked; Will Digital Health be the Exception?",
"headTitle": "Women’s Health | KQED Future of You | KQED Science",
"content": "\u003cdiv class=\"page\" title=\"Page 1\">\n\u003cdiv class=\"layoutArea\">\n\u003cdiv class=\"column\">\n\u003cp>\u003cem>Editor's note: This perspective comes from Gabrielle Guthrie. She is co- founder of the women-centered design start up, Moxxly, which is developing the world's first 'smart breast pump'. Gabrielle has a masters in design from Stanford University and lives and works in San Francisco.\u003c/em>\u003c/p>\n\u003cp>Women’s health is often assumed to be similar to men's health. Or not considered at all.\u003c/p>\n\u003cp>That needs to change.\u003c/p>\n\u003cp>In 1956, a clinical trial of the drug Thalidomide ran in the United States involving 875 people. Thalidomide was touted as a wonder drug for insomnia, headaches, and morning sickness. Pregnant women were among the participants. Within five years, Thalidomide \u003ca href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1849348/\">was pulled from the market\u003c/a> under pressure from the public after it caused malformation of the limbs in 10,000 children and killed an additional 2,000.\u003c/p>\n\u003cp>Following the Thalidomide scare, the industry still considers women to be a higher risk – and therefore a more expensive – participant group. So without requirements in place for industry to include a balanced representation of women, study participants skew heavily male.\u003c/p>\n\u003cp>So now, what is known to be true for men has been assumed to be true for everyone.\u003c/p>\n\u003cp>This assumption is especially dangerous with heart disease, the number one cause of death for women in the United States. Despite its fatality rate – or perhaps because of it - men comprise 76 percent of all heart-related study participants, even after efforts from the FDA Office of Women’s Health has worked to promote gender and racial diversity in the face of industry’s biases toward white, male enrollment in medical studies.\u003c/p>\n\u003cp>\u003cstrong>So What’s the Big Deal?\u003c/strong>\u003c/p>\n\u003cp>The problem occurs when insights from research are applied universally.\u003c/p>\n\u003cp>That left arm tingle we all associate with a classic sign of a heart attack?\u003c/p>\n\u003cp>Turns out that’s actually a classic sign of a heart attack in a man. A woman having a heart attack \u003ca href=\"http://www.npr.org/blogs/health/2015/04/06/397281837/women-having-a-heart-attack-dont-get-treatment-fast-enough\">can present much different symptoms\u003c/a>, such as fatigue, dizziness, or nausea.\u003c/p>\n\u003cp>“Many, many women died because the way we’re taught to recognize a heart attack is based on the symptoms men present,” says Dr. Alicia Carrasco, an internist affiliated with University of California, San Francisco (UCSF) Medical Center.\u003c/p>\n\u003cp>Studies with a gender imbalance can have a double blind affect: Patients may not realize the severity of their symptoms and doctors are more likely to misdiagnose them, with potentially fatal consequences.\u003c/p>\n\u003cp>Heart disease research is not an isolated instance. Non-smoking women for example, are more likely than men to develop lung cancer and we don’t know why. Women are also at a greater risk for depression.\u003c/p>\n\u003cp>Breast cancer research stands as a strong exception to this rule, with $6 billion raised every year. From 2011 to 2013 the National Cancer Institute allocated more than double the amount of funding for breast cancer research than for prostate cancer research, even though one in 31 women will die of breast cancer and one in 38 men will die of prostate cancer.\u003c/p>\n\u003c/div>\n\u003c/div>\n\u003c/div>\n\u003cdiv class=\"page\" title=\"Page 2\">\n\u003cdiv class=\"layoutArea\">\n\u003cdiv class=\"column\">\n\u003cp>But as the NFL goes pink for all of October, heart disease continues to kill one in three American women, according to the American Heart Association. In other words women in the U.S. are ten times more likely to die of heart disease than of breast cancer.\u003c/p>\n\u003cp>Yet cardiovascular disease is still considered a man’s disease.\u003c/p>\n\u003cp>\u003cstrong>Can New Digital Health Tools Change the Ratio?\u003cbr>\n\u003c/strong>\u003c/p>\n\u003cp>This lack of education and understanding of women’s health spreads across the health landscape from research studies to new digital health products.\u003c/p>\n\u003cp>Apple’s \u003ca href=\"http://www.theverge.com/2014/9/25/6844021/apple-promised-an-expansive-health-app-so-why-cant-i-track\">oversight in not including menstruation cycles\u003c/a> in its HealthKit service’s otherwise comprehensive metrics stands as a recent example. Despite the flak it received in the press, the latest software update still doesn’t offer the one health metric many women of childbearing age care most about: Period-tracking.\u003c/p>\n\u003cp>Experts say these types of examples are a frequent oversight, as both the technology and health fields are dominated by men.\u003c/p>\n\u003cp>Which means health issues that affect women are often either overlooked, in the case of HealthKit, or they miss the mark. Most women’s health apps still rely on and reinforce stereotypes of femininity that many women don’t identify with. Yes I’m talking pinks and flowers for everything from period trackers to breastfeeding.\u003c/p>\n\u003cp>“It may not even be a conscious thing. There are just more male doctors,\" said Dr. Carrasco.\u003c/p>\n\u003cp>\"In order for this to change, we need more women in positions of power.\"\u003c/p>\n\u003cp>And engineers, entrepreneurs and venture capitalists.\u003c/p>\n\u003cp>In my opinion, we’re still in the stage of women’s digital health that is operating on stereotypes and assumptions.\u003c/p>\n\u003cp>But digital health offers a new opportunity of understanding beyond the white, male patient.\u003c/p>\n\u003cp>\"We don’t have to rely on scientific studies and pharmaceutical companies to advance female health when we can collect vast quantities of valuable data on our own,” \u003ca href=\"http://pixelhealth.net/author/ida-tin/\">writes Ida Tin\u003c/a>, chief executive of Clue, an app that is focused on fertility.\u003c/p>\n\u003cp>But in order to be successful, women’s digital health products have to be designed for and with women in mind.\u003c/p>\n\u003c/div>\n\u003c/div>\n\u003c/div>\n\u003cp>[ad fullwidth]\u003c/p>\u003cp>\u003c/p>\n",
"disqusIdentifier": "2703 http://ww2.kqed.org/futureofyou/?p=2703",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2015/05/15/womens-health-is-too-often-overlooked-will-digital-health-be-the-exception/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 878,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 31
},
"modified": 1596839357,
"excerpt": "In order to be successful, women’s digital health products have to be designed for and with women in mind.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "In order to be successful, women’s digital health products have to be designed for and with women in mind.",
"title": "Women’s Health is Too Often Overlooked; Will Digital Health be the Exception? - KQED Future of You",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Women's Health is Too Often Overlooked; Will Digital Health be the Exception?",
"datePublished": "2015-05-15T10:15:07-07:00",
"dateModified": "2020-08-07T15:29:17-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [
{
"lastName": "Guthrie",
"yahooim": "",
"website": "",
"jabber": "",
"aim": "",
"displayName": "Gabrielle Guthrie",
"linkedAccount": "",
"description": "Gabrielle Guthrie has a Masters in Design from Stanford University. She is co-founder of the women-centered design start up, Moxxly. She lives and works in San Francisco.",
"type": "guest-author",
"userNicename": "gabrielle-guthrie",
"userLogin": "gabrielle-guthrie",
"firstName": "Gabrielle",
"userEmail": "gabrielle@moxxly.com",
"ID": "2718"
}
],
"slug": "womens-health-is-too-often-overlooked-will-digital-health-be-the-exception",
"status": "publish",
"templateType": "standard",
"featuredImageType": "standard",
"path": "/futureofyou/2703/womens-health-is-too-often-overlooked-will-digital-health-be-the-exception",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cdiv class=\"page\" title=\"Page 1\">\n\u003cdiv class=\"layoutArea\">\n\u003cdiv class=\"column\">\n\u003cp>\u003cem>Editor's note: This perspective comes from Gabrielle Guthrie. She is co- founder of the women-centered design start up, Moxxly, which is developing the world's first 'smart breast pump'. Gabrielle has a masters in design from Stanford University and lives and works in San Francisco.\u003c/em>\u003c/p>\n\u003cp>Women’s health is often assumed to be similar to men's health. Or not considered at all.\u003c/p>\n\u003cp>That needs to change.\u003c/p>\n\u003cp>In 1956, a clinical trial of the drug Thalidomide ran in the United States involving 875 people. Thalidomide was touted as a wonder drug for insomnia, headaches, and morning sickness. Pregnant women were among the participants. Within five years, Thalidomide \u003ca href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1849348/\">was pulled from the market\u003c/a> under pressure from the public after it caused malformation of the limbs in 10,000 children and killed an additional 2,000.\u003c/p>\n\u003cp>Following the Thalidomide scare, the industry still considers women to be a higher risk – and therefore a more expensive – participant group. So without requirements in place for industry to include a balanced representation of women, study participants skew heavily male.\u003c/p>\n\u003cp>So now, what is known to be true for men has been assumed to be true for everyone.\u003c/p>\n\u003cp>This assumption is especially dangerous with heart disease, the number one cause of death for women in the United States. Despite its fatality rate – or perhaps because of it - men comprise 76 percent of all heart-related study participants, even after efforts from the FDA Office of Women’s Health has worked to promote gender and racial diversity in the face of industry’s biases toward white, male enrollment in medical studies.\u003c/p>\n\u003cp>\u003cstrong>So What’s the Big Deal?\u003c/strong>\u003c/p>\n\u003cp>The problem occurs when insights from research are applied universally.\u003c/p>\n\u003cp>That left arm tingle we all associate with a classic sign of a heart attack?\u003c/p>\n\u003cp>Turns out that’s actually a classic sign of a heart attack in a man. A woman having a heart attack \u003ca href=\"http://www.npr.org/blogs/health/2015/04/06/397281837/women-having-a-heart-attack-dont-get-treatment-fast-enough\">can present much different symptoms\u003c/a>, such as fatigue, dizziness, or nausea.\u003c/p>\n\u003cp>“Many, many women died because the way we’re taught to recognize a heart attack is based on the symptoms men present,” says Dr. Alicia Carrasco, an internist affiliated with University of California, San Francisco (UCSF) Medical Center.\u003c/p>\n\u003cp>Studies with a gender imbalance can have a double blind affect: Patients may not realize the severity of their symptoms and doctors are more likely to misdiagnose them, with potentially fatal consequences.\u003c/p>\n\u003cp>Heart disease research is not an isolated instance. Non-smoking women for example, are more likely than men to develop lung cancer and we don’t know why. Women are also at a greater risk for depression.\u003c/p>\n\u003cp>Breast cancer research stands as a strong exception to this rule, with $6 billion raised every year. From 2011 to 2013 the National Cancer Institute allocated more than double the amount of funding for breast cancer research than for prostate cancer research, even though one in 31 women will die of breast cancer and one in 38 men will die of prostate cancer.\u003c/p>\n\u003c/div>\n\u003c/div>\n\u003c/div>\n\u003cdiv class=\"page\" title=\"Page 2\">\n\u003cdiv class=\"layoutArea\">\n\u003cdiv class=\"column\">\n\u003cp>But as the NFL goes pink for all of October, heart disease continues to kill one in three American women, according to the American Heart Association. In other words women in the U.S. are ten times more likely to die of heart disease than of breast cancer.\u003c/p>\n\u003cp>Yet cardiovascular disease is still considered a man’s disease.\u003c/p>\n\u003cp>\u003cstrong>Can New Digital Health Tools Change the Ratio?\u003cbr>\n\u003c/strong>\u003c/p>\n\u003cp>This lack of education and understanding of women’s health spreads across the health landscape from research studies to new digital health products.\u003c/p>\n\u003cp>Apple’s \u003ca href=\"http://www.theverge.com/2014/9/25/6844021/apple-promised-an-expansive-health-app-so-why-cant-i-track\">oversight in not including menstruation cycles\u003c/a> in its HealthKit service’s otherwise comprehensive metrics stands as a recent example. Despite the flak it received in the press, the latest software update still doesn’t offer the one health metric many women of childbearing age care most about: Period-tracking.\u003c/p>\n\u003cp>Experts say these types of examples are a frequent oversight, as both the technology and health fields are dominated by men.\u003c/p>\n\u003cp>Which means health issues that affect women are often either overlooked, in the case of HealthKit, or they miss the mark. Most women’s health apps still rely on and reinforce stereotypes of femininity that many women don’t identify with. Yes I’m talking pinks and flowers for everything from period trackers to breastfeeding.\u003c/p>\n\u003cp>“It may not even be a conscious thing. There are just more male doctors,\" said Dr. Carrasco.\u003c/p>\n\u003cp>\"In order for this to change, we need more women in positions of power.\"\u003c/p>\n\u003cp>And engineers, entrepreneurs and venture capitalists.\u003c/p>\n\u003cp>In my opinion, we’re still in the stage of women’s digital health that is operating on stereotypes and assumptions.\u003c/p>\n\u003cp>But digital health offers a new opportunity of understanding beyond the white, male patient.\u003c/p>\n\u003cp>\"We don’t have to rely on scientific studies and pharmaceutical companies to advance female health when we can collect vast quantities of valuable data on our own,” \u003ca href=\"http://pixelhealth.net/author/ida-tin/\">writes Ida Tin\u003c/a>, chief executive of Clue, an app that is focused on fertility.\u003c/p>\n\u003cp>But in order to be successful, women’s digital health products have to be designed for and with women in mind.\u003c/p>\n\u003c/div>\n\u003c/div>\n\u003c/div>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/2703/womens-health-is-too-often-overlooked-will-digital-health-be-the-exception",
"authors": [
"2718"
],
"series": [
"futureofyou_172",
"futureofyou_219"
],
"categories": [
"futureofyou_1060",
"futureofyou_1062"
],
"tags": [
"futureofyou_235",
"futureofyou_264",
"futureofyou_103",
"futureofyou_175",
"futureofyou_34",
"futureofyou_273",
"futureofyou_80",
"futureofyou_269",
"futureofyou_276",
"futureofyou_275"
],
"featImg": "futureofyou_2707",
"label": "futureofyou_219"
},
"futureofyou_2981": {
"type": "posts",
"id": "futureofyou_2981",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "2981",
"score": null,
"sort": [
1431619203000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou",
"term": 219
},
"blocks": [],
"publishDate": 1431619203,
"format": "image",
"disqusTitle": "D-Rev CEO: We Build Medical Devices for People who Live on Less than $4 a Day",
"title": "D-Rev CEO: We Build Medical Devices for People who Live on Less than $4 a Day",
"headTitle": "Women’s Health | KQED Future of You | KQED Science",
"content": "\u003cp>Most medical equipment companies don't regularly top \"\u003ca href=\"http://www.fastcompany.com/most-innovative-companies/2013/d-rev\">most innovative\u003c/a>\" lists.\u003c/p>\n\u003cp>But \u003ca href=\"http://d-rev.org/\">D-Rev\u003c/a> isn't your typical medical device maker. The San Francisco-based non-profit wants to help the world's poorest individuals, who subsist on less than a few dollars per day. Its products include an \u003ca href=\"http://d-rev.org/projects/mobility/\">$80 prosthetic knee\u003c/a> and a \u003ca href=\"http://d-rev.org/2010/12/brilliance-is-licensed-to-phoenix-medical/\">phototherapy device\u003c/a> to treat infants with jaundice.\u003c/p>\n\u003cp>[Skip to the bottom of the article to watch a TED talk on the $80 ReMotion knee.]\u003c/p>\n\u003cp>What's unique about D-Rev is its approach to research. The company sends its small team of designers into the field -- whether it's a rural village in India or a remote hospital in Uganda -- to conduct interviews with patients, doctors and nurses.\u003c/p>\n\u003cp>During a recent conversation with a doctor based in rural India, D-Rev employees learned that many babies were dying of jaundice. The treatment devices were too expensive to maintain. The team brainstormed low-cost solutions and came up with \u003ca href=\"http://d-rev.org/projects/newborn-health/\">Brilliance\u003c/a>, a photo-therapy lamp that sells for $400, a fraction of the cost of its mainstream competitors.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>\u003cem>KQED\u003c/em> sat down with Krista Donaldson, the company's chief executive, to discuss the ongoing challenges of running a medical non-profit and the opportunities for the future. Donaldson shared that D-Rev is considering a move into the U.S. market to help those in need closer to home.\u003c/p>\n\u003cp>This interview has been condensed and edited for brevity.\u003c/p>\n\u003cp>\u003cstrong>In the past few years, D-Rev seems to have exploded in the media. When did the company get its start?\u003c/strong>\u003c/p>\n\u003cp>It was started in 2008 as a skunk-works of technology for the developing world. I was brought in because a lot of the products were in stages of prototyping and weren't reaching users. I cancelled most of the projects and focused our attention on people who are living on less than $4 a day. Our core mission is to close the gap in quality health care by focusing on delivery and design.\u003c/p>\n\u003cp>\u003cstrong>What was the first product that you released as CEO?\u003c/strong>\u003c/p>\n\u003cp>It was the Brilliance photo-therapy device. We got the idea after a doctor from India approached us at a conference. He said that the global health community, which is very Western-driven, is focused on the 'big ticket items' like preterm births and asphyxia [\u003cspan class=\"st\">a potentially-fatal condition caused by a lack of oxygen in the blood\u003c/span>.] But he told us that at his hospital, many babies were dying of jaundice. We estimate that 6 million babies with severe jaundice are not receiving adequate treatment.\u003c/p>\n\u003cp>My colleague got intrigued about developing a device that would shine an intense, blue light onto the baby's skin as a safe and effective therapy. We had heard that a hospital in Uganda was putting babies in the sun to get treated. This isn't safe, but the doctor did that because it was his only option.\u003c/p>\n\u003cp>[Watch the video below to learn more about D-Rev's solution.]\u003c/p>\n\u003cp>[youtube http://www.youtube.com/watch?v=eOgPT0faICs]\u003c/p>\n\u003cp>\u003cstrong>Many medical device companies will donate surplus equipment to developing nations. So why would health providers buy a product from D-Rev?\u003c/strong>\u003c/p>\n\u003cp>The medical device industry is far behind in terms of design. The approach they often take when thinking about low-income people is to donate the stuff that isn't being used in the West. There are all sorts of problems with that, whether it's different electronic frequencies, plugs and outlets, fluctuating temperature standards, or broader cultural issues.\u003c/p>\n\u003cp>\u003cstrong>How about low-income people in the U.S. who struggle to access cost-effective therapies? Are you planning to build devices for the domestic market?\u003c/strong>\u003c/p>\n\u003cp>Yes. We are in the early exploration phases of looking into low-income amputees in the United States. If we do something, it'll be a version of our prosthetic knee. The problem is that devices are so expensive here that many low-income people we've spoken to say they are ordering stuff from China on eBay. We'll have more information about our next steps later in the year.\u003c/p>\n\u003cp>\u003cstrong>What's your design process like for developing a new medical device?\u003c/strong>\u003c/p>\n\u003caside class=\"pullquote alignright\">“ There were these teeny tiny babies that could fit in the palm of your hand. And they were under these photo-therapy devices that I could tell were ineffective in one glance.\"\u003cbr>\n\u003ccite>Krista Donaldson, CEO of D-Rev \u003c/cite>\u003c/aside>\n\u003cp>We start with a problem identified by a user, oftentimes a doctor at a rural clinic. One example might be a lack of high-quality, affordable prosthetic knees. We would ask questions to potential users like: 'Would you want a prosthetic that will help with your gait? Are you looking for a device that will help you to return to work?'\u003c/p>\n\u003cp>When we were doing the prototype of \u003ca href=\"http://d-rev.org/2014/10/learning-comet-rural-clinics-home-care-arent-ready-phototherapy/\">Comet\u003c/a>, an offshoot of our Brilliance phototherapy device, we drove around India and stopped at 20 different hospitals and clinics of all sizes to talk to the doctors. At this stage, we had four rough prototypes. Once you get more information, you can show the prototypes and get feedback. We also take into account cultural norms.\u003c/p>\n\u003cp>Once the product has been designed, we deal with things like regulation and intellectual property. Regulation is different in every country -- some have no requirements at all.\u003c/p>\n\u003cfigure id=\"attachment_2989\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003cimg class=\"size-medium wp-image-2989\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2015/05/Krista-Donaldson-talking-to-an-amputee-800x533.jpg\" alt=\"Donaldson interviewing an amputee \" width=\"800\" height=\"533\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2015/05/Krista-Donaldson-talking-to-an-amputee-800x533.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2015/05/Krista-Donaldson-talking-to-an-amputee-400x267.jpg 400w, https://ww2.kqed.org/app/uploads/sites/13/2015/05/Krista-Donaldson-talking-to-an-amputee-960x640.jpg 960w, https://ww2.kqed.org/app/uploads/sites/13/2015/05/Krista-Donaldson-talking-to-an-amputee.jpg 1025w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003cfigcaption class=\"wp-caption-text\">Donaldson interviewing an amputee victim \u003ccite>(D-Rev)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>\u003cstrong>Travel to rural parts of the world is expensive. Is it an ongoing challenge to raise funding?\u003c/strong>\u003c/p>\n\u003cp>We are raising money constantly. It is a challenge because we are more like a medical device startup than a typical philanthropic organization. We don't fit neatly into a bucket within the global health community, like\u003ca href=\"http://www.usaid.gov/\"> USAID [the government agency responsible for administering foreign aid.] \u003c/a>Their typical idea of global health innovation tends to be very labs-based.\u003c/p>\n\u003cp>But we have had a lot of success with foundations and individuals. Some companies help us out too, like \u003ca href=\"http://autodesk.com\">Autodesk\u003c/a>, which provides free software.\u003c/p>\n\u003cp>One big frustration I have is that big funders want to see data about improving mortality rates. They are less inclined to fund devices that prevent brain damage, rather than just save lives. We have to make sure that people can live healthy lives.\u003c/p>\n\u003cp>\u003cstrong>Aside from funding, what are some of the biggest hurdles that the company faces?\u003c/strong>\u003c/p>\n\u003cp>A lot of our users have low-trust in medical devices in general, in large part due to poor quality of some of the less expensive ones. Doctors often say to us: 'Why is your product so cheap? What's wrong with it?'\u003c/p>\n\u003cp>Another lesson learned is that in many low-income countries the government will purchase large batches of medical devices for state hospitals. They put out a tender with specifications that companies need to meet. I expected there to be less corruption in that process. But I'm hoping that things will improve over time with greater transparency.\u003c/p>\n\u003cp>\u003cstrong>What is the core demographic for D-Rev's devices?\u003c/strong>\u003c/p>\n\u003cp>We don't have any good data yet. But we are starting to do some preliminary research on gender. We have learned that boy babies are brought in for jaundice far more frequently than the girls -- it's about two to one. But boys and girl babies are equally likely to suffer from jaundice.\u003c/p>\n\u003cfigure id=\"attachment_2993\" class=\"wp-caption alignright\" style=\"max-width: 326px\">\u003cimg class=\" wp-image-2993\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2015/05/Bangladesh-Photo-450x600.jpg\" alt=\"A snap of some data compiled by a hospital in Bangladesh\" width=\"326\" height=\"435\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2015/05/Bangladesh-Photo-450x600.jpg 450w, https://ww2.kqed.org/app/uploads/sites/13/2015/05/Bangladesh-Photo-400x533.jpg 400w, https://ww2.kqed.org/app/uploads/sites/13/2015/05/Bangladesh-Photo.jpg 843w\" sizes=\"(max-width: 326px) 100vw, 326px\">\u003cfigcaption class=\"wp-caption-text\">A snap of some data compiled by a hospital in Bangladesh \u003ccite>(D-Rev)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>We had heard that stat anecdotally for a long time, but it wasn't really apparent until we were in a hospital in Bangladesh last year and spotted a board filled with the data. It clearly showed more male babies.\u003c/p>\n\u003cp>We're spotting similar trends with our research into prosthetics. Female amputees will come into the clinic less frequently than men. We think it may be related to social stigma.\u003c/p>\n\u003cp>\u003cstrong>What have been a few of your high and low points at D-Rev?\u003c/strong>\u003c/p>\n\u003cp>My background is that I worked in Kenya for a number of years designing water pumps for farmers. I don't have as much experience in health.\u003c/p>\n\u003cp>The first time I was in a hospital in India, it was very upsetting. I was a new mother myself. There were these teeny tiny babies that could fit in the palm of your hand. And they were under these photo-therapy devices that I could tell were ineffective in one glance.\u003c/p>\n\u003cp>It was a low point, because I couldn't help but step back and think, 'these are lives that could be damaged permanently, but it's all so easily fixed.' My goal now is for everyone on our team to undertake at least one trip like this a year.\u003c/p>\n\u003cp>A high-point involves meetings with our users. I met a young woman called Poornima, who lost her leg in a car accident. She lost her brother in that accident. Poornima had wanted to be an engineer. Now, she wears one of our prosthetic knees and is filled with renewed energy.\u003c/p>\n\u003cp>\u003cstrong>In SIlicon Valley, almost every company is fighting to hire good designers and engineers. Do you find it difficult to find and retain talent?\u003c/strong>\u003c/p>\n\u003cp>I have this frustration that the nonprofit sector pays very talented people not very much money because they have chosen this field. We try to pay people market salaries, despite the push-back from donors. I think our employees are worth even more than what we're paying them.\u003c/p>\n\u003cp>Overall though, we've done well with recruiting. Where it gets challenging is with more senior staff; people with nonprofit experience and medical device experience.\u003c/p>\n\u003cp>\u003cstrong>Any parting words of wisdom for would-be health entrepreneurs who want to help low-income people?\u003c/strong>\u003c/p>\n\u003cp>Get out there and get experience. Talk to people; learn how to frame questions. Every time I go on vacation for instance, I stop into clinics and hospitals that use our products. Whenever I do field work, I always learn new things.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>[ted id=1895]\u003c/p>\n\n",
"disqusIdentifier": "2981 http://ww2.kqed.org/futureofyou/?p=2981",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2015/05/14/d-rev-ceo-we-build-medical-devices-for-people-who-live-on-less-than-4-a-day/",
"stats": {
"hasVideo": true,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1658,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 46
},
"modified": 1477282577,
"excerpt": "D-Rev CEO Krista Donaldson on selling medical devices to hospitals and clinics in the world's poorest communities. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "D-Rev CEO Krista Donaldson on selling medical devices to hospitals and clinics in the world's poorest communities. ",
"title": "D-Rev CEO: We Build Medical Devices for People who Live on Less than $4 a Day | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "D-Rev CEO: We Build Medical Devices for People who Live on Less than $4 a Day",
"datePublished": "2015-05-14T09:00:03-07:00",
"dateModified": "2016-10-23T21:16:17-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "d-rev-ceo-we-build-medical-devices-for-people-who-live-on-less-than-4-a-day",
"status": "publish",
"path": "/futureofyou/2981/d-rev-ceo-we-build-medical-devices-for-people-who-live-on-less-than-4-a-day",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Most medical equipment companies don't regularly top \"\u003ca href=\"http://www.fastcompany.com/most-innovative-companies/2013/d-rev\">most innovative\u003c/a>\" lists.\u003c/p>\n\u003cp>But \u003ca href=\"http://d-rev.org/\">D-Rev\u003c/a> isn't your typical medical device maker. The San Francisco-based non-profit wants to help the world's poorest individuals, who subsist on less than a few dollars per day. Its products include an \u003ca href=\"http://d-rev.org/projects/mobility/\">$80 prosthetic knee\u003c/a> and a \u003ca href=\"http://d-rev.org/2010/12/brilliance-is-licensed-to-phoenix-medical/\">phototherapy device\u003c/a> to treat infants with jaundice.\u003c/p>\n\u003cp>[Skip to the bottom of the article to watch a TED talk on the $80 ReMotion knee.]\u003c/p>\n\u003cp>What's unique about D-Rev is its approach to research. The company sends its small team of designers into the field -- whether it's a rural village in India or a remote hospital in Uganda -- to conduct interviews with patients, doctors and nurses.\u003c/p>\n\u003cp>During a recent conversation with a doctor based in rural India, D-Rev employees learned that many babies were dying of jaundice. The treatment devices were too expensive to maintain. The team brainstormed low-cost solutions and came up with \u003ca href=\"http://d-rev.org/projects/newborn-health/\">Brilliance\u003c/a>, a photo-therapy lamp that sells for $400, a fraction of the cost of its mainstream competitors.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\u003cem>KQED\u003c/em> sat down with Krista Donaldson, the company's chief executive, to discuss the ongoing challenges of running a medical non-profit and the opportunities for the future. Donaldson shared that D-Rev is considering a move into the U.S. market to help those in need closer to home.\u003c/p>\n\u003cp>This interview has been condensed and edited for brevity.\u003c/p>\n\u003cp>\u003cstrong>In the past few years, D-Rev seems to have exploded in the media. When did the company get its start?\u003c/strong>\u003c/p>\n\u003cp>It was started in 2008 as a skunk-works of technology for the developing world. I was brought in because a lot of the products were in stages of prototyping and weren't reaching users. I cancelled most of the projects and focused our attention on people who are living on less than $4 a day. Our core mission is to close the gap in quality health care by focusing on delivery and design.\u003c/p>\n\u003cp>\u003cstrong>What was the first product that you released as CEO?\u003c/strong>\u003c/p>\n\u003cp>It was the Brilliance photo-therapy device. We got the idea after a doctor from India approached us at a conference. He said that the global health community, which is very Western-driven, is focused on the 'big ticket items' like preterm births and asphyxia [\u003cspan class=\"st\">a potentially-fatal condition caused by a lack of oxygen in the blood\u003c/span>.] But he told us that at his hospital, many babies were dying of jaundice. We estimate that 6 million babies with severe jaundice are not receiving adequate treatment.\u003c/p>\n\u003cp>My colleague got intrigued about developing a device that would shine an intense, blue light onto the baby's skin as a safe and effective therapy. We had heard that a hospital in Uganda was putting babies in the sun to get treated. This isn't safe, but the doctor did that because it was his only option.\u003c/p>\n\u003cp>[Watch the video below to learn more about D-Rev's solution.]\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003cspan class='utils-parseShortcode-shortcodes-__youtubeShortcode__embedYoutube'>\n \u003cspan class='utils-parseShortcode-shortcodes-__youtubeShortcode__embedYoutubeInside'>\n \u003ciframe\n loading='lazy'\n class='utils-parseShortcode-shortcodes-__youtubeShortcode__youtubePlayer'\n type='text/html'\n src='//www.youtube.com/embed/eOgPT0faICs'\n title='//www.youtube.com/embed/eOgPT0faICs'\n allowfullscreen='true'\n style='border:0;'>\u003c/iframe>\n \u003c/span>\n \u003c/span>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\u003cstrong>Many medical device companies will donate surplus equipment to developing nations. So why would health providers buy a product from D-Rev?\u003c/strong>\u003c/p>\n\u003cp>The medical device industry is far behind in terms of design. The approach they often take when thinking about low-income people is to donate the stuff that isn't being used in the West. There are all sorts of problems with that, whether it's different electronic frequencies, plugs and outlets, fluctuating temperature standards, or broader cultural issues.\u003c/p>\n\u003cp>\u003cstrong>How about low-income people in the U.S. who struggle to access cost-effective therapies? Are you planning to build devices for the domestic market?\u003c/strong>\u003c/p>\n\u003cp>Yes. We are in the early exploration phases of looking into low-income amputees in the United States. If we do something, it'll be a version of our prosthetic knee. The problem is that devices are so expensive here that many low-income people we've spoken to say they are ordering stuff from China on eBay. We'll have more information about our next steps later in the year.\u003c/p>\n\u003cp>\u003cstrong>What's your design process like for developing a new medical device?\u003c/strong>\u003c/p>\n\u003caside class=\"pullquote alignright\">“ There were these teeny tiny babies that could fit in the palm of your hand. And they were under these photo-therapy devices that I could tell were ineffective in one glance.\"\u003cbr>\n\u003ccite>Krista Donaldson, CEO of D-Rev \u003c/cite>\u003c/aside>\n\u003cp>We start with a problem identified by a user, oftentimes a doctor at a rural clinic. One example might be a lack of high-quality, affordable prosthetic knees. We would ask questions to potential users like: 'Would you want a prosthetic that will help with your gait? Are you looking for a device that will help you to return to work?'\u003c/p>\n\u003cp>When we were doing the prototype of \u003ca href=\"http://d-rev.org/2014/10/learning-comet-rural-clinics-home-care-arent-ready-phototherapy/\">Comet\u003c/a>, an offshoot of our Brilliance phototherapy device, we drove around India and stopped at 20 different hospitals and clinics of all sizes to talk to the doctors. At this stage, we had four rough prototypes. Once you get more information, you can show the prototypes and get feedback. We also take into account cultural norms.\u003c/p>\n\u003cp>Once the product has been designed, we deal with things like regulation and intellectual property. Regulation is different in every country -- some have no requirements at all.\u003c/p>\n\u003cfigure id=\"attachment_2989\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003cimg class=\"size-medium wp-image-2989\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2015/05/Krista-Donaldson-talking-to-an-amputee-800x533.jpg\" alt=\"Donaldson interviewing an amputee \" width=\"800\" height=\"533\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2015/05/Krista-Donaldson-talking-to-an-amputee-800x533.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2015/05/Krista-Donaldson-talking-to-an-amputee-400x267.jpg 400w, https://ww2.kqed.org/app/uploads/sites/13/2015/05/Krista-Donaldson-talking-to-an-amputee-960x640.jpg 960w, https://ww2.kqed.org/app/uploads/sites/13/2015/05/Krista-Donaldson-talking-to-an-amputee.jpg 1025w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003cfigcaption class=\"wp-caption-text\">Donaldson interviewing an amputee victim \u003ccite>(D-Rev)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>\u003cstrong>Travel to rural parts of the world is expensive. Is it an ongoing challenge to raise funding?\u003c/strong>\u003c/p>\n\u003cp>We are raising money constantly. It is a challenge because we are more like a medical device startup than a typical philanthropic organization. We don't fit neatly into a bucket within the global health community, like\u003ca href=\"http://www.usaid.gov/\"> USAID [the government agency responsible for administering foreign aid.] \u003c/a>Their typical idea of global health innovation tends to be very labs-based.\u003c/p>\n\u003cp>But we have had a lot of success with foundations and individuals. Some companies help us out too, like \u003ca href=\"http://autodesk.com\">Autodesk\u003c/a>, which provides free software.\u003c/p>\n\u003cp>One big frustration I have is that big funders want to see data about improving mortality rates. They are less inclined to fund devices that prevent brain damage, rather than just save lives. We have to make sure that people can live healthy lives.\u003c/p>\n\u003cp>\u003cstrong>Aside from funding, what are some of the biggest hurdles that the company faces?\u003c/strong>\u003c/p>\n\u003cp>A lot of our users have low-trust in medical devices in general, in large part due to poor quality of some of the less expensive ones. Doctors often say to us: 'Why is your product so cheap? What's wrong with it?'\u003c/p>\n\u003cp>Another lesson learned is that in many low-income countries the government will purchase large batches of medical devices for state hospitals. They put out a tender with specifications that companies need to meet. I expected there to be less corruption in that process. But I'm hoping that things will improve over time with greater transparency.\u003c/p>\n\u003cp>\u003cstrong>What is the core demographic for D-Rev's devices?\u003c/strong>\u003c/p>\n\u003cp>We don't have any good data yet. But we are starting to do some preliminary research on gender. We have learned that boy babies are brought in for jaundice far more frequently than the girls -- it's about two to one. But boys and girl babies are equally likely to suffer from jaundice.\u003c/p>\n\u003cfigure id=\"attachment_2993\" class=\"wp-caption alignright\" style=\"max-width: 326px\">\u003cimg class=\" wp-image-2993\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2015/05/Bangladesh-Photo-450x600.jpg\" alt=\"A snap of some data compiled by a hospital in Bangladesh\" width=\"326\" height=\"435\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2015/05/Bangladesh-Photo-450x600.jpg 450w, https://ww2.kqed.org/app/uploads/sites/13/2015/05/Bangladesh-Photo-400x533.jpg 400w, https://ww2.kqed.org/app/uploads/sites/13/2015/05/Bangladesh-Photo.jpg 843w\" sizes=\"(max-width: 326px) 100vw, 326px\">\u003cfigcaption class=\"wp-caption-text\">A snap of some data compiled by a hospital in Bangladesh \u003ccite>(D-Rev)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>We had heard that stat anecdotally for a long time, but it wasn't really apparent until we were in a hospital in Bangladesh last year and spotted a board filled with the data. It clearly showed more male babies.\u003c/p>\n\u003cp>We're spotting similar trends with our research into prosthetics. Female amputees will come into the clinic less frequently than men. We think it may be related to social stigma.\u003c/p>\n\u003cp>\u003cstrong>What have been a few of your high and low points at D-Rev?\u003c/strong>\u003c/p>\n\u003cp>My background is that I worked in Kenya for a number of years designing water pumps for farmers. I don't have as much experience in health.\u003c/p>\n\u003cp>The first time I was in a hospital in India, it was very upsetting. I was a new mother myself. There were these teeny tiny babies that could fit in the palm of your hand. And they were under these photo-therapy devices that I could tell were ineffective in one glance.\u003c/p>\n\u003cp>It was a low point, because I couldn't help but step back and think, 'these are lives that could be damaged permanently, but it's all so easily fixed.' My goal now is for everyone on our team to undertake at least one trip like this a year.\u003c/p>\n\u003cp>A high-point involves meetings with our users. I met a young woman called Poornima, who lost her leg in a car accident. She lost her brother in that accident. Poornima had wanted to be an engineer. Now, she wears one of our prosthetic knees and is filled with renewed energy.\u003c/p>\n\u003cp>\u003cstrong>In SIlicon Valley, almost every company is fighting to hire good designers and engineers. Do you find it difficult to find and retain talent?\u003c/strong>\u003c/p>\n\u003cp>I have this frustration that the nonprofit sector pays very talented people not very much money because they have chosen this field. We try to pay people market salaries, despite the push-back from donors. I think our employees are worth even more than what we're paying them.\u003c/p>\n\u003cp>Overall though, we've done well with recruiting. Where it gets challenging is with more senior staff; people with nonprofit experience and medical device experience.\u003c/p>\n\u003cp>\u003cstrong>Any parting words of wisdom for would-be health entrepreneurs who want to help low-income people?\u003c/strong>\u003c/p>\n\u003cp>Get out there and get experience. Talk to people; learn how to frame questions. Every time I go on vacation for instance, I stop into clinics and hospitals that use our products. Whenever I do field work, I always learn new things.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>[ted id=1895]\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/2981/d-rev-ceo-we-build-medical-devices-for-people-who-live-on-less-than-4-a-day",
"authors": [
"3252"
],
"series": [
"futureofyou_135",
"futureofyou_219"
],
"categories": [
"futureofyou_1062"
],
"tags": [
"futureofyou_316",
"futureofyou_320",
"futureofyou_322",
"futureofyou_80",
"futureofyou_317",
"futureofyou_321",
"futureofyou_319",
"futureofyou_323",
"futureofyou_318"
],
"featImg": "futureofyou_2987",
"label": "futureofyou_219"
},
"futureofyou_2853": {
"type": "posts",
"id": "futureofyou_2853",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "2853",
"score": null,
"sort": [
1431104093000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou",
"term": 172
},
"blocks": [],
"publishDate": 1431104093,
"format": "standard",
"disqusTitle": "DNA 'Printing' a Big Boon to Research, But Some Raise Concerns",
"title": "DNA 'Printing' a Big Boon to Research, But Some Raise Concerns",
"headTitle": "Contributor | KQED Future of You | KQED Science",
"content": "\u003cp>Here's something that might sound strange: There are companies now that print and sell DNA.\u003c/p>\n\u003cp>This trend — which uses the term \"print\" in the sense of making a bunch of copies speedily — is making particular stretches of \u003ca href=\"http://ghr.nlm.nih.gov/handbook/basics/dna\">DNA\u003c/a> much cheaper and easier to obtain than ever before. That excites many scientists who are keen to use these tailored strings of genetic instructions to do all sorts of things, ranging from finding new medical treatments to genetically engineering better crops.\u003c/p>\n\u003cp>\"So much good can be done,\" says Austen Heinz, CEO of \u003ca href=\"http://cambriangenomics.com/\">Cambrian Genomics \u003c/a>in San Francisco, one of the companies selling these stretches of DNA.\u003c/p>\n\u003cp>But some of the ways Heinz and others talk about the possible uses of the technology also worries some people who are keeping tabs on the trend.\u003c/p>\n\u003cp>\"I have significant concerns,\" says \u003ca href=\"http://www.geneticsandsociety.org/article.php?id=2081\">Marcy Darnovsky\u003c/a>, who directs the Center for Genetics and Society, a genetics watchdog group.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>A number of companies have been taking advantage of several recent advances in technology to produce DNA quickly and cheaply. Heinz says his company has made the process even cheaper.\u003c/p>\n\u003cp>\"Everyone else that makes DNA, makes DNA incorrectly and then tries to fix it,\" Heinz says. \"We don't fix it. We just see what's good, what's bad and then we use the correct pieces.\"\u003c/p>\n\u003cp>The company does that by putting chunks of their DNA on tiny metal beads that emit different colors. That lets a computer scan millions of pieces of DNA to find the right ones.\u003c/p>\n\u003cp>\"So we just take a picture, change a filter, take a picture, change a filter, take a picture, change a filter. And we read the sequences,\" he says.\u003c/p>\n\u003cp>It's basically a high-tech version of a spell-checker.\u003c/p>\n\u003cp>Then Cambrian chooses and \"prints\" the correct stretch of DNA by firing a computer-controlled laser beam at a glass tray holding millions of these tiny metal beads, each one coated with DNA\u003cstrong>.\u003c/strong> The impact of the laser propels the bead carrying the correct DNA into a tray.\u003c/p>\n\u003cp>\"The DNA laser 'printer' is essentially a sorter,\" he says. It can produce any strand of DNA, made to order, and Heinz can crank out a lot of DNA this way.\u003c/p>\n\u003cp>So far, the company's main customers are drug companies, which use the strings of DNA Cambrian Genomics makes to do things like genetically engineer microbes to try to find new medicines.\u003c/p>\n\u003cp>\"They may be interested in making a protein that attacks a cancer cell with some kind of killer payload,\" he says.\u003c/p>\n\u003cp>Other users are genetically engineering plants to try to make them grow better. But Heinz envisions a day when mass-produced DNA can genetically engineer people — or let anyone use DNA like computer code to design their own organisms.\u003c/p>\n\u003cp>\"I think some people will find the process of designing and making organisms just fun, in and of itself,\" he says.\u003c/p>\n\u003cp>But this sort of talk makes some people nervous.\u003c/p>\n\u003cp>\"Heinz talks openly about everybody being able to create entirely novel creatures,\" Darnovsky says. \"Is that what we want? Do we want anybody, including potential terrorists, to be able to create entirely novel life forms — new creatures? Do we want the teenager next door to be creating Godzilla in the bathtub? I don't want that.\"\u003c/p>\n\u003cp>She also worries about genetically engineered plants running amok, ruining the environment. And, she says, genetically engineering people would be even worse.\u003c/p>\n\u003cp>\"Many of the figures in the synthetic biology field are not shy at all about embracing that prospect that we're going to use synthetic biology to redesign humanity and to engineer the traits in our children,\" she says. \"And that I find extremely disturbing.\"\u003c/p>\n\u003cp>But others say those kinds of fears are exaggerated.\u003c/p>\n\u003cp>\"Like every other technology, we need to be paying attention to how it's used,\" says \u003ca href=\"http://www.biodesic.com/People.html\">Rob Carlson\u003c/a>, a biotechnology analyst at Seattle-based \u003ca href=\"http://www.biodesic.com/index.html\">Biodesic\u003c/a>. But \"it is not intrinsically more dangerous than other technologies,\" he adds. \"And, in fact, if you wanted to do harm, there are many easier ways to go about causing harm than using synthetic DNA.\"\u003c/p>\n\u003cp>Heinz says his company is being very careful. It won't sell DNA to just anyone. And the potential benefits to society, he thinks, are huge.\u003c/p>\n\u003cp>\"We can make DNA that would be used to make a virus that could target your cancer cells. And I think it can be helpful for dealing with some of the problems that humans have created. If we can make plants that can suck more carbon out of the atmosphere, we can deal with global warming,\" he says.\u003c/p>\n\u003cp>In addition, Heinz says he thinks \"in general most people want children that are healthier than they were — maybe better. I think as a race, or as a species we have a goal of improving who we are.\"\u003c/p>\n\u003cp>Already, Cambrian Genomics and other companies are scaling up their operations to meet what many expect to be a growing demand for synthetic DNA.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003ca href=\"http://www.npr.org/blogs/health/2015/05/07/404460240/dna-printing-a-big-boon-to-research-but-some-raise-concerns\">Read the full transcript of the interview here.\u003c/a>\u003c/p>\n\u003cdiv class=\"fullattribution\">\u003cem>Copyright 2015 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=DNA+%27Printing%27+A+Big+Boon+To+Research%2C+But+Some+Raise+Concerns&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\" alt=\"\">\u003c/em>\u003c/div>\n\n",
"disqusIdentifier": "2853 http://ww2.kqed.org/futureofyou/?p=2853",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2015/05/08/dna-printing-a-big-boon-to-research-but-some-raise-concerns/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 855,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 29
},
"modified": 1477282638,
"excerpt": "Companies are assembling and churning out tailored stretches of DNA faster and more cheaply than ever before. The tool speeds research into diseases of plants and people. But what about eugenics?",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Companies are assembling and churning out tailored stretches of DNA faster and more cheaply than ever before. The tool speeds research into diseases of plants and people. But what about eugenics?",
"title": "DNA 'Printing' a Big Boon to Research, But Some Raise Concerns | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "DNA 'Printing' a Big Boon to Research, But Some Raise Concerns",
"datePublished": "2015-05-08T09:54:53-07:00",
"dateModified": "2016-10-23T21:17:18-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "dna-printing-a-big-boon-to-research-but-some-raise-concerns",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=404460240&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Rob Stein",
"nprStoryDate": "Thu, 07 May 2015 16:56:00 -0400",
"nprLastModifiedDate": "Thu, 07 May 2015 19:21:24 -0400",
"nprHtmlLink": "http://www.npr.org/blogs/health/2015/05/07/404460240/dna-printing-a-big-boon-to-research-but-some-raise-concerns?ft=nprml&f=404460240",
"nprAudio": "http://pd.npr.org/anon.npr-mp3/npr/atc/2015/05/20150507_atc_suggested_uses_of_easy_dna_printing_raise_concerns.mp3?orgId=1&topicId=1128&d=384&p=2&story=404460240&t=progseg&e=404994164&seg=14&ft=nprml&f=404460240",
"nprAudioM3u": "http://api.npr.org/m3u/1404994340-99e895.m3u?orgId=1&topicId=1128&d=384&p=2&story=404460240&t=progseg&e=404994164&seg=14&ft=nprml&f=404460240",
"nprStoryId": "404460240",
"nprRetrievedStory": "1",
"nprPubDate": "Thu, 07 May 2015 19:21:00 -0400",
"path": "/futureofyou/2853/dna-printing-a-big-boon-to-research-but-some-raise-concerns",
"audioUrl": "http://pd.npr.org/anon.npr-mp3/npr/atc/2015/05/20150507_atc_suggested_uses_of_easy_dna_printing_raise_concerns.mp3?orgId=1&topicId=1128&d=384&p=2&story=404460240&t=progseg&e=404994164&seg=14&ft=nprml&f=404460240",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Here's something that might sound strange: There are companies now that print and sell DNA.\u003c/p>\n\u003cp>This trend — which uses the term \"print\" in the sense of making a bunch of copies speedily — is making particular stretches of \u003ca href=\"http://ghr.nlm.nih.gov/handbook/basics/dna\">DNA\u003c/a> much cheaper and easier to obtain than ever before. That excites many scientists who are keen to use these tailored strings of genetic instructions to do all sorts of things, ranging from finding new medical treatments to genetically engineering better crops.\u003c/p>\n\u003cp>\"So much good can be done,\" says Austen Heinz, CEO of \u003ca href=\"http://cambriangenomics.com/\">Cambrian Genomics \u003c/a>in San Francisco, one of the companies selling these stretches of DNA.\u003c/p>\n\u003cp>But some of the ways Heinz and others talk about the possible uses of the technology also worries some people who are keeping tabs on the trend.\u003c/p>\n\u003cp>\"I have significant concerns,\" says \u003ca href=\"http://www.geneticsandsociety.org/article.php?id=2081\">Marcy Darnovsky\u003c/a>, who directs the Center for Genetics and Society, a genetics watchdog group.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>A number of companies have been taking advantage of several recent advances in technology to produce DNA quickly and cheaply. Heinz says his company has made the process even cheaper.\u003c/p>\n\u003cp>\"Everyone else that makes DNA, makes DNA incorrectly and then tries to fix it,\" Heinz says. \"We don't fix it. We just see what's good, what's bad and then we use the correct pieces.\"\u003c/p>\n\u003cp>The company does that by putting chunks of their DNA on tiny metal beads that emit different colors. That lets a computer scan millions of pieces of DNA to find the right ones.\u003c/p>\n\u003cp>\"So we just take a picture, change a filter, take a picture, change a filter, take a picture, change a filter. And we read the sequences,\" he says.\u003c/p>\n\u003cp>It's basically a high-tech version of a spell-checker.\u003c/p>\n\u003cp>Then Cambrian chooses and \"prints\" the correct stretch of DNA by firing a computer-controlled laser beam at a glass tray holding millions of these tiny metal beads, each one coated with DNA\u003cstrong>.\u003c/strong> The impact of the laser propels the bead carrying the correct DNA into a tray.\u003c/p>\n\u003cp>\"The DNA laser 'printer' is essentially a sorter,\" he says. It can produce any strand of DNA, made to order, and Heinz can crank out a lot of DNA this way.\u003c/p>\n\u003cp>So far, the company's main customers are drug companies, which use the strings of DNA Cambrian Genomics makes to do things like genetically engineer microbes to try to find new medicines.\u003c/p>\n\u003cp>\"They may be interested in making a protein that attacks a cancer cell with some kind of killer payload,\" he says.\u003c/p>\n\u003cp>Other users are genetically engineering plants to try to make them grow better. But Heinz envisions a day when mass-produced DNA can genetically engineer people — or let anyone use DNA like computer code to design their own organisms.\u003c/p>\n\u003cp>\"I think some people will find the process of designing and making organisms just fun, in and of itself,\" he says.\u003c/p>\n\u003cp>But this sort of talk makes some people nervous.\u003c/p>\n\u003cp>\"Heinz talks openly about everybody being able to create entirely novel creatures,\" Darnovsky says. \"Is that what we want? Do we want anybody, including potential terrorists, to be able to create entirely novel life forms — new creatures? Do we want the teenager next door to be creating Godzilla in the bathtub? I don't want that.\"\u003c/p>\n\u003cp>She also worries about genetically engineered plants running amok, ruining the environment. And, she says, genetically engineering people would be even worse.\u003c/p>\n\u003cp>\"Many of the figures in the synthetic biology field are not shy at all about embracing that prospect that we're going to use synthetic biology to redesign humanity and to engineer the traits in our children,\" she says. \"And that I find extremely disturbing.\"\u003c/p>\n\u003cp>But others say those kinds of fears are exaggerated.\u003c/p>\n\u003cp>\"Like every other technology, we need to be paying attention to how it's used,\" says \u003ca href=\"http://www.biodesic.com/People.html\">Rob Carlson\u003c/a>, a biotechnology analyst at Seattle-based \u003ca href=\"http://www.biodesic.com/index.html\">Biodesic\u003c/a>. But \"it is not intrinsically more dangerous than other technologies,\" he adds. \"And, in fact, if you wanted to do harm, there are many easier ways to go about causing harm than using synthetic DNA.\"\u003c/p>\n\u003cp>Heinz says his company is being very careful. It won't sell DNA to just anyone. And the potential benefits to society, he thinks, are huge.\u003c/p>\n\u003cp>\"We can make DNA that would be used to make a virus that could target your cancer cells. And I think it can be helpful for dealing with some of the problems that humans have created. If we can make plants that can suck more carbon out of the atmosphere, we can deal with global warming,\" he says.\u003c/p>\n\u003cp>In addition, Heinz says he thinks \"in general most people want children that are healthier than they were — maybe better. I think as a race, or as a species we have a goal of improving who we are.\"\u003c/p>\n\u003cp>Already, Cambrian Genomics and other companies are scaling up their operations to meet what many expect to be a growing demand for synthetic DNA.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003ca href=\"http://www.npr.org/blogs/health/2015/05/07/404460240/dna-printing-a-big-boon-to-research-but-some-raise-concerns\">Read the full transcript of the interview here.\u003c/a>\u003c/p>\n\u003cdiv class=\"fullattribution\">\u003cem>Copyright 2015 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=DNA+%27Printing%27+A+Big+Boon+To+Research%2C+But+Some+Raise+Concerns&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\" alt=\"\">\u003c/em>\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/2853/dna-printing-a-big-boon-to-research-but-some-raise-concerns",
"authors": [
"byline_futureofyou_2853"
],
"series": [
"futureofyou_172"
],
"categories": [
"futureofyou_1062",
"futureofyou_1064"
],
"tags": [
"futureofyou_17",
"futureofyou_292",
"futureofyou_138",
"futureofyou_295",
"futureofyou_19",
"futureofyou_80",
"futureofyou_294",
"futureofyou_271"
],
"featImg": "futureofyou_2856",
"label": "futureofyou_172"
},
"futureofyou_839": {
"type": "posts",
"id": "futureofyou_839",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "839",
"score": null,
"sort": [
1427392017000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou"
},
"blocks": [],
"publishDate": 1427392017,
"format": "standard",
"disqusTitle": "University and Biotech Firm Team Up on Colorblindness Therapy",
"title": "University and Biotech Firm Team Up on Colorblindness Therapy",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>More than 10 million Americans have trouble distinguishing red from green or blue from yellow, and there's no treatment for colorblindness.\u003c/p>\n\u003cp>A biotech company and two scientists hope to change that.\u003c/p>\n\u003cp>On Wednesday, Avalanche Biotechnologies in Menlo Park and the University of Washington in Seattle \u003ca href=\"http://investors.avalanchebiotech.com/phoenix.zhtml?c=253634&p=irol-newsArticle&ID=2028354\">announced\u003c/a> a licensing agreement to develop the first treatment for colorblindness. The deal brings together a gene therapy technique developed by Avalanche with the expertise of vision researchers at the University of Washington.\u003c/p>\n\u003cp>\"Our goal is to be treating colorblindness in clinical trials in patients in the next one to two years,\" says \u003ca href=\"http://www.avalanchebiotech.com/founders-and-management-team.php\">Thomas Chalberg\u003c/a>, the founder and CEO of Avalanche.\u003c/p>\n\u003cp>The agreement has its roots in a scientific breakthrough that occurred six years ago. That's when two vision researchers at the University of Washington used gene therapy to \u003ca href=\"http://www.npr.org/templates/story/story.php?storyId=112897277\">cure\u003c/a> a common form of colorblindness in squirrel monkeys.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>\"This opened the possibility of ultimately getting this to cure colorblindness in humans,\" says \u003ca href=\"http://depts.washington.edu/givemed/prof-chair/holders/jay-neitz/\">Jay Neitz\u003c/a>, who runs the \u003ca href=\"http://www.neitzvision.com/content/people.html\">Color Vision Lab\u003c/a> at UW along with his wife, \u003ca href=\"http://depts.washington.edu/givemed/prof-chair/holders/maureen-neitz/\">Maureen Neitz\u003c/a>.\u003c/p>\n\u003cp>The couple knew that transferring their success from monkey to man would be a challenge. But they were determined, says Maureen Neitz. \"We've spent our entire careers writing NIH grants where we say our goal is to improve human health.\"\u003c/p>\n\u003cp>Colorblindness is usually a genetic disorder. About 8 percent of men inherit a mutation on the X chromosome that makes it hard for them to distinguish between red and green. The condition affects only about 0.5 percent of women, who have two X chromosomes.\u003c/p>\n\u003cp>And color vision problems can be disabling. Emails arrive every day at Neitz lab with subject lines saying things like \"colorblindness ruined my life,\" says Jay Neitz.\u003c/p>\n\u003cp>The stories often come from people who say they are unable to pursue careers as pilots or fire fighters or even electricians, whose work involves a lot of color-coded wires.\u003c/p>\n\u003cfigure id=\"attachment_844\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003ca href=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde.jpg\">\u003cimg class=\"wp-image-844 size-medium\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-800x507.jpg\" alt=\"Dalton the squirrel monkey during the color vision test. (Courtesy Neitz Laboratory)\" width=\"800\" height=\"507\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-800x507.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-400x253.jpg 400w, https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-1180x747.jpg 1180w, https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-768x486.jpg 768w, https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-320x203.jpg 320w, https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde.jpg 1500w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Dalton the squirrel monkey during the color vision test.\u003cbr> (Courtesy Neitz Laboratory)\u003c/figcaption>\u003c/figure>\n\u003cp>Colorblindness can also make it hard to do things like drive after dark, says Maureen Neitz. That became a big problem for her brother, who is colorblind, after his community switched from mercury street lamps, which give off bluish light, to sodium street lamps, which produce orange light.\u003c/p>\n\u003cp>\"He came home and he was shaking,\" Maureen Neitz says. \"He said everything was just a sea of lights, it was all the same colors. (He) could not tell the street lights from the brake lights from the stoplights.\"\u003c/p>\n\u003cp>Curing colorblindness involves delivering new genes to cells in the retina that respond to color. That's how Jay and Maureen Neitz cured the squirrel monkeys six years ago. But the technique they used required surgery on the retina, which is risky.\u003c/p>\n\u003cp>For people they needed a nonsurgical approach, something that had eluded researchers for years. Then a team at the University of California, Berkeley found a way to deliver genes using a simple injection into the vitreous, the clear gel that fills most of the eyeball.\u003c/p>\n\u003cp>Avalanche Biotechnologies has been working to improve and commercialize the Berkeley technique, says Chalberg. When he met Jay and Maureen Neitz at a scientific conference in 2012, he says, it was clear they could work together.\u003c/p>\n\u003cp>It should be possible to begin experimentally treating patients within a couple of years, Chalberg says, because the human eye has proved to be a safe and relatively easy place to use gene therapy. \"We like to say what happens in the eye stays in the eye, because it's kind of this small enclosed space.\"\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>And a cure for colorblindness has the potential to help millions of people, Chalberg says. \"People with this vision disorder have a very limited sensation,\" he says. \"They can only see about 1 percent of the colors of a normal person. And so in some ways it's actually closer to being blind than it is to being sighted.\"\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2015 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=University+And+Biotech+Firm+Team+Up+On+Colorblindness+Therapy&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\" alt=\"\">\u003c/div>\n\n",
"disqusIdentifier": "839 http://ww2.kqed.org/futureofyou/?p=839",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2015/03/26/university-and-biotech-firm-team-up-on-colorblindness-therapy/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 668,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 19
},
"modified": 1477283444,
"excerpt": "Six years ago, husband-and-wife scientists used gene therapy to cure colorblindness in monkeys. Now they're trying to make it work for the millions of people with faulty color vision.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Six years ago, husband-and-wife scientists used gene therapy to cure colorblindness in monkeys. Now they're trying to make it work for the millions of people with faulty color vision.",
"title": "University and Biotech Firm Team Up on Colorblindness Therapy | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "University and Biotech Firm Team Up on Colorblindness Therapy",
"datePublished": "2015-03-26T10:46:57-07:00",
"dateModified": "2016-10-23T21:30:44-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "university-and-biotech-firm-team-up-on-colorblindness-therapy",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=395303785&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Jon Hamilton",
"nprStoryDate": "Wed, 25 Mar 2015 16:14:00 -0400",
"nprLastModifiedDate": "Wed, 25 Mar 2015 17:01:08 -0400",
"nprHtmlLink": "http://www.npr.org/blogs/health/2015/03/25/395303785/university-and-biotech-firm-team-up-on-colorblindness-therapy?ft=nprml&f=395303785",
"nprAudio": "http://pd.npr.org/anon.npr-mp3/npr/atc/2015/03/20150325_atc_a_university_and_a_biotech_firm_team_up_to_treat_colorblindness.mp3?orgId=1&topicId=1128&e=395303785&d=235&ft=nprml&f=395303785",
"nprAudioM3u": "http://api.npr.org/m3u/1395355187-8703a7.m3u?orgId=1&topicId=1128&e=395303785&d=235&ft=nprml&f=395303785",
"nprStoryId": "395303785",
"nprRetrievedStory": "1",
"nprPubDate": "Wed, 25 Mar 2015 20:00:00 -0400",
"path": "/futureofyou/839/university-and-biotech-firm-team-up-on-colorblindness-therapy",
"audioUrl": "http://pd.npr.org/anon.npr-mp3/npr/atc/2015/03/20150325_atc_a_university_and_a_biotech_firm_team_up_to_treat_colorblindness.mp3?orgId=1&topicId=1128&e=395303785&d=235&ft=nprml&f=395303785",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>More than 10 million Americans have trouble distinguishing red from green or blue from yellow, and there's no treatment for colorblindness.\u003c/p>\n\u003cp>A biotech company and two scientists hope to change that.\u003c/p>\n\u003cp>On Wednesday, Avalanche Biotechnologies in Menlo Park and the University of Washington in Seattle \u003ca href=\"http://investors.avalanchebiotech.com/phoenix.zhtml?c=253634&p=irol-newsArticle&ID=2028354\">announced\u003c/a> a licensing agreement to develop the first treatment for colorblindness. The deal brings together a gene therapy technique developed by Avalanche with the expertise of vision researchers at the University of Washington.\u003c/p>\n\u003cp>\"Our goal is to be treating colorblindness in clinical trials in patients in the next one to two years,\" says \u003ca href=\"http://www.avalanchebiotech.com/founders-and-management-team.php\">Thomas Chalberg\u003c/a>, the founder and CEO of Avalanche.\u003c/p>\n\u003cp>The agreement has its roots in a scientific breakthrough that occurred six years ago. That's when two vision researchers at the University of Washington used gene therapy to \u003ca href=\"http://www.npr.org/templates/story/story.php?storyId=112897277\">cure\u003c/a> a common form of colorblindness in squirrel monkeys.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\"This opened the possibility of ultimately getting this to cure colorblindness in humans,\" says \u003ca href=\"http://depts.washington.edu/givemed/prof-chair/holders/jay-neitz/\">Jay Neitz\u003c/a>, who runs the \u003ca href=\"http://www.neitzvision.com/content/people.html\">Color Vision Lab\u003c/a> at UW along with his wife, \u003ca href=\"http://depts.washington.edu/givemed/prof-chair/holders/maureen-neitz/\">Maureen Neitz\u003c/a>.\u003c/p>\n\u003cp>The couple knew that transferring their success from monkey to man would be a challenge. But they were determined, says Maureen Neitz. \"We've spent our entire careers writing NIH grants where we say our goal is to improve human health.\"\u003c/p>\n\u003cp>Colorblindness is usually a genetic disorder. About 8 percent of men inherit a mutation on the X chromosome that makes it hard for them to distinguish between red and green. The condition affects only about 0.5 percent of women, who have two X chromosomes.\u003c/p>\n\u003cp>And color vision problems can be disabling. Emails arrive every day at Neitz lab with subject lines saying things like \"colorblindness ruined my life,\" says Jay Neitz.\u003c/p>\n\u003cp>The stories often come from people who say they are unable to pursue careers as pilots or fire fighters or even electricians, whose work involves a lot of color-coded wires.\u003c/p>\n\u003cfigure id=\"attachment_844\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003ca href=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde.jpg\">\u003cimg class=\"wp-image-844 size-medium\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-800x507.jpg\" alt=\"Dalton the squirrel monkey during the color vision test. (Courtesy Neitz Laboratory)\" width=\"800\" height=\"507\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-800x507.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-400x253.jpg 400w, https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-1180x747.jpg 1180w, https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-768x486.jpg 768w, https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde-320x203.jpg 320w, https://ww2.kqed.org/app/uploads/sites/13/2015/03/dalton_enl-00dfdb2bfbf90d194783e9854671a7c715cebdde.jpg 1500w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Dalton the squirrel monkey during the color vision test.\u003cbr> (Courtesy Neitz Laboratory)\u003c/figcaption>\u003c/figure>\n\u003cp>Colorblindness can also make it hard to do things like drive after dark, says Maureen Neitz. That became a big problem for her brother, who is colorblind, after his community switched from mercury street lamps, which give off bluish light, to sodium street lamps, which produce orange light.\u003c/p>\n\u003cp>\"He came home and he was shaking,\" Maureen Neitz says. \"He said everything was just a sea of lights, it was all the same colors. (He) could not tell the street lights from the brake lights from the stoplights.\"\u003c/p>\n\u003cp>Curing colorblindness involves delivering new genes to cells in the retina that respond to color. That's how Jay and Maureen Neitz cured the squirrel monkeys six years ago. But the technique they used required surgery on the retina, which is risky.\u003c/p>\n\u003cp>For people they needed a nonsurgical approach, something that had eluded researchers for years. Then a team at the University of California, Berkeley found a way to deliver genes using a simple injection into the vitreous, the clear gel that fills most of the eyeball.\u003c/p>\n\u003cp>Avalanche Biotechnologies has been working to improve and commercialize the Berkeley technique, says Chalberg. When he met Jay and Maureen Neitz at a scientific conference in 2012, he says, it was clear they could work together.\u003c/p>\n\u003cp>It should be possible to begin experimentally treating patients within a couple of years, Chalberg says, because the human eye has proved to be a safe and relatively easy place to use gene therapy. \"We like to say what happens in the eye stays in the eye, because it's kind of this small enclosed space.\"\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>And a cure for colorblindness has the potential to help millions of people, Chalberg says. \"People with this vision disorder have a very limited sensation,\" he says. \"They can only see about 1 percent of the colors of a normal person. And so in some ways it's actually closer to being blind than it is to being sighted.\"\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2015 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=University+And+Biotech+Firm+Team+Up+On+Colorblindness+Therapy&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\" alt=\"\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/839/university-and-biotech-firm-team-up-on-colorblindness-therapy",
"authors": [
"byline_futureofyou_839"
],
"categories": [
"futureofyou_1062"
],
"tags": [
"futureofyou_126",
"futureofyou_80",
"futureofyou_125",
"futureofyou_127"
],
"featImg": "futureofyou_843",
"label": "futureofyou"
}
},
"podcastsReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"podcasts": {}
},
"radioProgramsReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"radioPrograms": {}
},
"radioSearchSegmentsReducer": {},
"programsReducer": {
"all-things-considered": {
"id": "all-things-considered",
"title": "All Things Considered",
"info": "Every weekday, \u003cem>All Things Considered\u003c/em> hosts Robert Siegel, Audie Cornish, Ari Shapiro, and Kelly McEvers present the program's trademark mix of news, interviews, commentaries, reviews, and offbeat features. Michel Martin hosts on the weekends.",
"airtime": "MON-FRI 1pm-2pm, 4:30pm-6:30pm\u003cbr />SAT-SUN 5pm-6pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/All-Things-Considered-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/all-things-considered/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/all-things-considered"
},
"american-suburb-podcast": {
"id": "american-suburb-podcast",
"title": "American Suburb: The Podcast",
"tagline": "The flip side of gentrification, told through one town",
"info": "Gentrification is changing cities across America, forcing people from neighborhoods they have long called home. Call them the displaced. Now those priced out of the Bay Area are looking for a better life in an unlikely place. American Suburb follows this migration to one California town along the Delta, 45 miles from San Francisco. But is this once sleepy suburb ready for them?",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/American-Suburb-Podcast-Tile-703x703-1.jpg",
"officialWebsiteLink": "/news/series/american-suburb-podcast",
"meta": {
"site": "news",
"source": "kqed",
"order": 19
},
"link": "/news/series/american-suburb-podcast/",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/RBrW",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?mt=2&id=1287748328",
"tuneIn": "https://tunein.com/radio/American-Suburb-p1086805/",
"rss": "https://ww2.kqed.org/news/series/american-suburb-podcast/feed/podcast",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkMzMDExODgxNjA5"
}
},
"baycurious": {
"id": "baycurious",
"title": "Bay Curious",
"tagline": "Exploring the Bay Area, one question at a time",
"info": "KQED’s new podcast, Bay Curious, gets to the bottom of the mysteries — both profound and peculiar — that give the Bay Area its unique identity. And we’ll do it with your help! You ask the questions. You decide what Bay Curious investigates. And you join us on the journey to find the answers.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Bay-Curious-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Bay Curious",
"officialWebsiteLink": "/news/series/baycurious",
"meta": {
"site": "news",
"source": "kqed",
"order": 3
},
"link": "/podcasts/baycurious",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/bay-curious/id1172473406",
"npr": "https://www.npr.org/podcasts/500557090/bay-curious",
"rss": "https://ww2.kqed.org/news/category/bay-curious-podcast/feed/podcast",
"amazon": "https://music.amazon.com/podcasts/9a90d476-aa04-455d-9a4c-0871ed6216d4/bay-curious",
"stitcher": "https://www.stitcher.com/podcast/kqed/bay-curious",
"spotify": "https://open.spotify.com/show/6O76IdmhixfijmhTZLIJ8k"
}
},
"bbc-world-service": {
"id": "bbc-world-service",
"title": "BBC World Service",
"info": "The day's top stories from BBC News compiled twice daily in the week, once at weekends.",
"airtime": "MON-FRI 9pm-10pm, TUE-FRI 1am-2am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/BBC-World-Service-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.bbc.co.uk/sounds/play/live:bbc_world_service",
"meta": {
"site": "news",
"source": "BBC World Service"
},
"link": "/radio/program/bbc-world-service",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/global-news-podcast/id135067274?mt=2",
"tuneIn": "https://tunein.com/radio/BBC-World-Service-p455581/",
"rss": "https://podcasts.files.bbci.co.uk/p02nq0gn.rss"
}
},
"californiareport": {
"id": "californiareport",
"title": "The California Report",
"tagline": "California, day by day",
"info": "KQED’s statewide radio news program providing daily coverage of issues, trends and public policy decisions.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-California-Report-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The California Report",
"officialWebsiteLink": "/californiareport",
"meta": {
"site": "news",
"source": "kqed",
"order": 8
},
"link": "/californiareport",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/kqeds-the-california-report/id79681292",
"amazon": "https://music.amazon.com/podcasts/26099305-72af-4542-9dde-ac1807fe36d5/kqed-s-the-california-report",
"npr": "https://www.npr.org/podcasts/432285393/the-california-report",
"stitcher": "https://www.stitcher.com/podcast/kqedfm-kqeds-the-california-report-podcast-8838",
"rss": "https://ww2.kqed.org/news/tag/tcram/feed/podcast"
}
},
"californiareportmagazine": {
"id": "californiareportmagazine",
"title": "The California Report Magazine",
"tagline": "Your state, your stories",
"info": "Every week, The California Report Magazine takes you on a road trip for the ears: to visit the places and meet the people who make California unique. The in-depth storytelling podcast from the California Report.",
"airtime": "FRI 4:30pm-5pm, 6:30pm-7pm, 11pm-11:30pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-California-Report-Magazine-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The California Report Magazine",
"officialWebsiteLink": "/californiareportmagazine",
"meta": {
"site": "news",
"source": "kqed",
"order": 10
},
"link": "/californiareportmagazine",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-california-report-magazine/id1314750545",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM3NjkwNjk1OTAz",
"npr": "https://www.npr.org/podcasts/564733126/the-california-report-magazine",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-california-report-magazine",
"rss": "https://ww2.kqed.org/news/tag/tcrmag/feed/podcast"
}
},
"city-arts": {
"id": "city-arts",
"title": "City Arts & Lectures",
"info": "A one-hour radio program to hear celebrated writers, artists and thinkers address contemporary ideas and values, often discussing the creative process. Please note: tapes or transcripts are not available",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/05/cityartsandlecture-300x300.jpg",
"officialWebsiteLink": "https://www.cityarts.net/",
"airtime": "SUN 1pm-2pm, TUE 10pm, WED 1am",
"meta": {
"site": "news",
"source": "City Arts & Lectures"
},
"link": "https://www.cityarts.net",
"subscribe": {
"tuneIn": "https://tunein.com/radio/City-Arts-and-Lectures-p692/",
"rss": "https://www.cityarts.net/feed/"
}
},
"closealltabs": {
"id": "closealltabs",
"title": "Close All Tabs",
"tagline": "Your irreverent guide to the trends redefining our world",
"info": "Close All Tabs breaks down how digital culture shapes our world through thoughtful insights and irreverent humor.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/02/CAT_2_Tile-scaled.jpg",
"imageAlt": "KQED Close All Tabs",
"officialWebsiteLink": "/podcasts/closealltabs",
"meta": {
"site": "news",
"source": "kqed",
"order": 1
},
"link": "/podcasts/closealltabs",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/close-all-tabs/id214663465",
"rss": "https://feeds.megaphone.fm/KQINC6993880386",
"amazon": "https://music.amazon.com/podcasts/92d9d4ac-67a3-4eed-b10a-fb45d45b1ef2/close-all-tabs",
"spotify": "https://open.spotify.com/show/6LAJFHnGK1pYXYzv6SIol6?si=deb0cae19813417c"
}
},
"code-switch-life-kit": {
"id": "code-switch-life-kit",
"title": "Code Switch / Life Kit",
"info": "\u003cem>Code Switch\u003c/em>, which listeners will hear in the first part of the hour, has fearless and much-needed conversations about race. Hosted by journalists of color, the show tackles the subject of race head-on, exploring how it impacts every part of society — from politics and pop culture to history, sports and more.\u003cbr />\u003cbr />\u003cem>Life Kit\u003c/em>, which will be in the second part of the hour, guides you through spaces and feelings no one prepares you for — from finances to mental health, from workplace microaggressions to imposter syndrome, from relationships to parenting. The show features experts with real world experience and shares their knowledge. Because everyone needs a little help being human.\u003cbr />\u003cbr />\u003ca href=\"https://www.npr.org/podcasts/510312/codeswitch\">\u003cem>Code Switch\u003c/em> offical site and podcast\u003c/a>\u003cbr />\u003ca href=\"https://www.npr.org/lifekit\">\u003cem>Life Kit\u003c/em> offical site and podcast\u003c/a>\u003cbr />",
"airtime": "SUN 9pm-10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Code-Switch-Life-Kit-Podcast-Tile-360x360-1.jpg",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/code-switch-life-kit",
"subscribe": {
"apple": "https://podcasts.apple.com/podcast/1112190608?mt=2&at=11l79Y&ct=nprdirectory",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly93d3cubnByLm9yZy9yc3MvcG9kY2FzdC5waHA_aWQ9NTEwMzEy",
"spotify": "https://open.spotify.com/show/3bExJ9JQpkwNhoHvaIIuyV",
"rss": "https://feeds.npr.org/510312/podcast.xml"
}
},
"commonwealth-club": {
"id": "commonwealth-club",
"title": "Commonwealth Club of California Podcast",
"info": "The Commonwealth Club of California is the nation's oldest and largest public affairs forum. As a non-partisan forum, The Club brings to the public airwaves diverse viewpoints on important topics. The Club's weekly radio broadcast - the oldest in the U.S., dating back to 1924 - is carried across the nation on public radio stations and is now podcasting. Our website archive features audio of our recent programs, as well as selected speeches from our long and distinguished history. This podcast feed is usually updated twice a week and is always un-edited.",
"airtime": "THU 10pm, FRI 1am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Commonwealth-Club-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.commonwealthclub.org/podcasts",
"meta": {
"site": "news",
"source": "Commonwealth Club of California"
},
"link": "/radio/program/commonwealth-club",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/commonwealth-club-of-california-podcast/id976334034?mt=2",
"google": "https://podcasts.google.com/feed/aHR0cDovL3d3dy5jb21tb253ZWFsdGhjbHViLm9yZy9hdWRpby9wb2RjYXN0L3dlZWtseS54bWw",
"tuneIn": "https://tunein.com/radio/Commonwealth-Club-of-California-p1060/"
}
},
"forum": {
"id": "forum",
"title": "Forum",
"tagline": "The conversation starts here",
"info": "KQED’s live call-in program discussing local, state, national and international issues, as well as in-depth interviews.",
"airtime": "MON-FRI 9am-11am, 10pm-11pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Forum-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Forum with Mina Kim and Alexis Madrigal",
"officialWebsiteLink": "/forum",
"meta": {
"site": "news",
"source": "kqed",
"order": 9
},
"link": "/forum",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/kqeds-forum/id73329719",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM5NTU3MzgxNjMz",
"npr": "https://www.npr.org/podcasts/432307980/forum",
"stitcher": "https://www.stitcher.com/podcast/kqedfm-kqeds-forum-podcast",
"rss": "https://feeds.megaphone.fm/KQINC9557381633"
}
},
"freakonomics-radio": {
"id": "freakonomics-radio",
"title": "Freakonomics Radio",
"info": "Freakonomics Radio is a one-hour award-winning podcast and public-radio project hosted by Stephen Dubner, with co-author Steve Levitt as a regular guest. It is produced in partnership with WNYC.",
"imageSrc": "https://ww2.kqed.org/news/wp-content/uploads/sites/10/2018/05/freakonomicsRadio.png",
"officialWebsiteLink": "http://freakonomics.com/",
"airtime": "SUN 1am-2am, SAT 3pm-4pm",
"meta": {
"site": "radio",
"source": "WNYC"
},
"link": "/radio/program/freakonomics-radio",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/4s8b",
"apple": "https://itunes.apple.com/us/podcast/freakonomics-radio/id354668519",
"tuneIn": "https://tunein.com/podcasts/WNYC-Podcasts/Freakonomics-Radio-p272293/",
"rss": "https://feeds.feedburner.com/freakonomicsradio"
}
},
"fresh-air": {
"id": "fresh-air",
"title": "Fresh Air",
"info": "Hosted by Terry Gross, \u003cem>Fresh Air from WHYY\u003c/em> is the Peabody Award-winning weekday magazine of contemporary arts and issues. One of public radio's most popular programs, Fresh Air features intimate conversations with today's biggest luminaries.",
"airtime": "MON-FRI 7pm-8pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Fresh-Air-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/fresh-air/",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/fresh-air",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/4s8b",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=214089682&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Fresh-Air-p17/",
"rss": "https://feeds.npr.org/381444908/podcast.xml"
}
},
"here-and-now": {
"id": "here-and-now",
"title": "Here & Now",
"info": "A live production of NPR and WBUR Boston, in collaboration with stations across the country, Here & Now reflects the fluid world of news as it's happening in the middle of the day, with timely, in-depth news, interviews and conversation. Hosted by Robin Young, Jeremy Hobson and Tonya Mosley.",
"airtime": "MON-THU 11am-12pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Here-And-Now-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "http://www.wbur.org/hereandnow",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/here-and-now",
"subsdcribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?mt=2&id=426698661",
"tuneIn": "https://tunein.com/radio/Here--Now-p211/",
"rss": "https://feeds.npr.org/510051/podcast.xml"
}
},
"hidden-brain": {
"id": "hidden-brain",
"title": "Hidden Brain",
"info": "Shankar Vedantam uses science and storytelling to reveal the unconscious patterns that drive human behavior, shape our choices and direct our relationships.",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/05/hiddenbrain.jpg",
"officialWebsiteLink": "https://www.npr.org/series/423302056/hidden-brain",
"airtime": "SUN 7pm-8pm",
"meta": {
"site": "news",
"source": "NPR"
},
"link": "/radio/program/hidden-brain",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/hidden-brain/id1028908750?mt=2",
"tuneIn": "https://tunein.com/podcasts/Science-Podcasts/Hidden-Brain-p787503/",
"rss": "https://feeds.npr.org/510308/podcast.xml"
}
},
"how-i-built-this": {
"id": "how-i-built-this",
"title": "How I Built This with Guy Raz",
"info": "Guy Raz dives into the stories behind some of the world's best known companies. How I Built This weaves a narrative journey about innovators, entrepreneurs and idealists—and the movements they built.",
"imageSrc": "https://ww2.kqed.org/news/wp-content/uploads/sites/10/2018/05/howIBuiltThis.png",
"officialWebsiteLink": "https://www.npr.org/podcasts/510313/how-i-built-this",
"airtime": "SUN 7:30pm-8pm",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/how-i-built-this",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/3zxy",
"apple": "https://itunes.apple.com/us/podcast/how-i-built-this-with-guy-raz/id1150510297?mt=2",
"tuneIn": "https://tunein.com/podcasts/Arts--Culture-Podcasts/How-I-Built-This-p910896/",
"rss": "https://feeds.npr.org/510313/podcast.xml"
}
},
"hyphenacion": {
"id": "hyphenacion",
"title": "Hyphenación",
"tagline": "Where conversation and cultura meet",
"info": "What kind of no sabo word is Hyphenación? For us, it’s about living within a hyphenation. Like being a third-gen Mexican-American from the Texas border now living that Bay Area Chicano life. Like Xorje! Each week we bring together a couple of hyphenated Latinos to talk all about personal life choices: family, careers, relationships, belonging … everything is on the table. ",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/03/Hyphenacion_FinalAssets_PodcastTile.png",
"imageAlt": "KQED Hyphenación",
"officialWebsiteLink": "/podcasts/hyphenacion",
"meta": {
"site": "news",
"source": "kqed",
"order": 15
},
"link": "/podcasts/hyphenacion",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/hyphenaci%C3%B3n/id1191591838",
"spotify": "https://open.spotify.com/show/2p3Fifq96nw9BPcmFdIq0o?si=39209f7b25774f38",
"youtube": "https://www.youtube.com/c/kqedarts",
"amazon": "https://music.amazon.com/podcasts/6c3dd23c-93fb-4aab-97ba-1725fa6315f1/hyphenaci%C3%B3n",
"rss": "https://feeds.megaphone.fm/KQINC2275451163"
}
},
"jerrybrown": {
"id": "jerrybrown",
"title": "The Political Mind of Jerry Brown",
"tagline": "Lessons from a lifetime in politics",
"info": "The Political Mind of Jerry Brown brings listeners the wisdom of the former Governor, Mayor, and presidential candidate. Scott Shafer interviewed Brown for more than 40 hours, covering the former governor's life and half-century in the political game – and Brown has some lessons he'd like to share. ",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Political-Mind-of-Jerry-Brown-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Political Mind of Jerry Brown",
"officialWebsiteLink": "/podcasts/jerrybrown",
"meta": {
"site": "news",
"source": "kqed",
"order": 18
},
"link": "/podcasts/jerrybrown",
"subscribe": {
"npr": "https://www.npr.org/podcasts/790253322/the-political-mind-of-jerry-brown",
"apple": "https://itunes.apple.com/us/podcast/id1492194549",
"rss": "https://ww2.kqed.org/news/series/jerrybrown/feed/podcast/",
"tuneIn": "http://tun.in/pjGcK",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-political-mind-of-jerry-brown",
"spotify": "https://open.spotify.com/show/54C1dmuyFyKMFttY6X2j6r?si=K8SgRCoISNK6ZbjpXrX5-w",
"amazon": "https://music.amazon.com/podcasts/44420f75-3b0e-4301-ab3b-16da6b09e543/the-political-mind-of-jerry-brown"
}
},
"latino-usa": {
"id": "latino-usa",
"title": "Latino USA",
"airtime": "MON 1am-2am, SUN 6pm-7pm",
"info": "Latino USA, the radio journal of news and culture, is the only national, English-language radio program produced from a Latino perspective.",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/latinoUsa.jpg",
"officialWebsiteLink": "http://latinousa.org/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/latino-usa",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/xtTd",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=79681317&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Latino-USA-p621/",
"rss": "https://feeds.npr.org/510016/podcast.xml"
}
},
"marketplace": {
"id": "marketplace",
"title": "Marketplace",
"info": "Our flagship program, helmed by Kai Ryssdal, examines what the day in money delivered, through stories, conversations, newsworthy numbers and more. Updated Monday through Friday at about 3:30 p.m. PT.",
"airtime": "MON-FRI 4pm-4:30pm, MON-WED 6:30pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Marketplace-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.marketplace.org/",
"meta": {
"site": "news",
"source": "American Public Media"
},
"link": "/radio/program/marketplace",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=201853034&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/APM-Marketplace-p88/",
"rss": "https://feeds.publicradio.org/public_feeds/marketplace-pm/rss/rss"
}
},
"masters-of-scale": {
"id": "masters-of-scale",
"title": "Masters of Scale",
"info": "Masters of Scale is an original podcast in which LinkedIn co-founder and Greylock Partner Reid Hoffman sets out to describe and prove theories that explain how great entrepreneurs take their companies from zero to a gazillion in ingenious fashion.",
"airtime": "Every other Wednesday June 12 through October 16 at 8pm (repeats Thursdays at 2am)",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Masters-of-Scale-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://mastersofscale.com/",
"meta": {
"site": "radio",
"source": "WaitWhat"
},
"link": "/radio/program/masters-of-scale",
"subscribe": {
"apple": "http://mastersofscale.app.link/",
"rss": "https://rss.art19.com/masters-of-scale"
}
},
"mindshift": {
"id": "mindshift",
"title": "MindShift",
"tagline": "A podcast about the future of learning and how we raise our kids",
"info": "The MindShift podcast explores the innovations in education that are shaping how kids learn. Hosts Ki Sung and Katrina Schwartz introduce listeners to educators, researchers, parents and students who are developing effective ways to improve how kids learn. We cover topics like how fed-up administrators are developing surprising tactics to deal with classroom disruptions; how listening to podcasts are helping kids develop reading skills; the consequences of overparenting; and why interdisciplinary learning can engage students on all ends of the traditional achievement spectrum. This podcast is part of the MindShift education site, a division of KQED News. KQED is an NPR/PBS member station based in San Francisco. You can also visit the MindShift website for episodes and supplemental blog posts or tweet us \u003ca href=\"https://twitter.com/MindShiftKQED\">@MindShiftKQED\u003c/a> or visit us at \u003ca href=\"/mindshift\">MindShift.KQED.org\u003c/a>",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Mindshift-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED MindShift: How We Will Learn",
"officialWebsiteLink": "/mindshift/",
"meta": {
"site": "news",
"source": "kqed",
"order": 12
},
"link": "/podcasts/mindshift",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/mindshift-podcast/id1078765985",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM1NzY0NjAwNDI5",
"npr": "https://www.npr.org/podcasts/464615685/mind-shift-podcast",
"stitcher": "https://www.stitcher.com/podcast/kqed/stories-teachers-share",
"spotify": "https://open.spotify.com/show/0MxSpNYZKNprFLCl7eEtyx"
}
},
"morning-edition": {
"id": "morning-edition",
"title": "Morning Edition",
"info": "\u003cem>Morning Edition\u003c/em> takes listeners around the country and the world with multi-faceted stories and commentaries every weekday. Hosts Steve Inskeep, David Greene and Rachel Martin bring you the latest breaking news and features to prepare you for the day.",
"airtime": "MON-FRI 3am-9am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Morning-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/morning-edition/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/morning-edition"
},
"onourwatch": {
"id": "onourwatch",
"title": "On Our Watch",
"tagline": "Deeply-reported investigative journalism",
"info": "For decades, the process for how police police themselves has been inconsistent – if not opaque. In some states, like California, these proceedings were completely hidden. After a new police transparency law unsealed scores of internal affairs files, our reporters set out to examine these cases and the shadow world of police discipline. On Our Watch brings listeners into the rooms where officers are questioned and witnesses are interrogated to find out who this system is really protecting. Is it the officers, or the public they've sworn to serve?",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/On-Our-Watch-Podcast-Tile-703x703-1.jpg",
"imageAlt": "On Our Watch from NPR and KQED",
"officialWebsiteLink": "/podcasts/onourwatch",
"meta": {
"site": "news",
"source": "kqed",
"order": 11
},
"link": "/podcasts/onourwatch",
"subscribe": {
"apple": "https://podcasts.apple.com/podcast/id1567098962",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5ucHIub3JnLzUxMDM2MC9wb2RjYXN0LnhtbD9zYz1nb29nbGVwb2RjYXN0cw",
"npr": "https://rpb3r.app.goo.gl/onourwatch",
"spotify": "https://open.spotify.com/show/0OLWoyizopu6tY1XiuX70x",
"tuneIn": "https://tunein.com/radio/On-Our-Watch-p1436229/",
"stitcher": "https://www.stitcher.com/show/on-our-watch",
"rss": "https://feeds.npr.org/510360/podcast.xml"
}
},
"on-the-media": {
"id": "on-the-media",
"title": "On The Media",
"info": "Our weekly podcast explores how the media 'sausage' is made, casts an incisive eye on fluctuations in the marketplace of ideas, and examines threats to the freedom of information and expression in America and abroad. For one hour a week, the show tries to lift the veil from the process of \"making media,\" especially news media, because it's through that lens that we see the world and the world sees us",
"airtime": "SUN 2pm-3pm, MON 12am-1am",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/onTheMedia.png",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/otm",
"meta": {
"site": "news",
"source": "wnyc"
},
"link": "/radio/program/on-the-media",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/on-the-media/id73330715?mt=2",
"tuneIn": "https://tunein.com/radio/On-the-Media-p69/",
"rss": "http://feeds.wnyc.org/onthemedia"
}
},
"pbs-newshour": {
"id": "pbs-newshour",
"title": "PBS NewsHour",
"info": "Analysis, background reports and updates from the PBS NewsHour putting today's news in context.",
"airtime": "MON-FRI 3pm-4pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/PBS-News-Hour-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.pbs.org/newshour/",
"meta": {
"site": "news",
"source": "pbs"
},
"link": "/radio/program/pbs-newshour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/pbs-newshour-full-show/id394432287?mt=2",
"tuneIn": "https://tunein.com/radio/PBS-NewsHour---Full-Show-p425698/",
"rss": "https://www.pbs.org/newshour/feeds/rss/podcasts/show"
}
},
"perspectives": {
"id": "perspectives",
"title": "Perspectives",
"tagline": "KQED's series of daily listener commentaries since 1991",
"info": "KQED's series of daily listener commentaries since 1991.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/01/Perspectives_Tile_Final.jpg",
"imageAlt": "KQED Perspectives",
"officialWebsiteLink": "/perspectives/",
"meta": {
"site": "radio",
"source": "kqed",
"order": 14
},
"link": "/perspectives",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/id73801135",
"npr": "https://www.npr.org/podcasts/432309616/perspectives",
"rss": "https://ww2.kqed.org/perspectives/category/perspectives/feed/",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly93dzIua3FlZC5vcmcvcGVyc3BlY3RpdmVzL2NhdGVnb3J5L3BlcnNwZWN0aXZlcy9mZWVkLw"
}
},
"planet-money": {
"id": "planet-money",
"title": "Planet Money",
"info": "The economy explained. Imagine you could call up a friend and say, Meet me at the bar and tell me what's going on with the economy. Now imagine that's actually a fun evening.",
"airtime": "SUN 3pm-4pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/planetmoney.jpg",
"officialWebsiteLink": "https://www.npr.org/sections/money/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/planet-money",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/M4f5",
"apple": "https://itunes.apple.com/us/podcast/planet-money/id290783428?mt=2",
"tuneIn": "https://tunein.com/podcasts/Business--Economics-Podcasts/Planet-Money-p164680/",
"rss": "https://feeds.npr.org/510289/podcast.xml"
}
},
"politicalbreakdown": {
"id": "politicalbreakdown",
"title": "Political Breakdown",
"tagline": "Politics from a personal perspective",
"info": "Political Breakdown is a new series that explores the political intersection of California and the nation. Each week hosts Scott Shafer and Marisa Lagos are joined with a new special guest to unpack politics -- with personality — and offer an insider’s glimpse at how politics happens.",
"airtime": "THU 6:30pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Political-Breakdown-2024-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Political Breakdown",
"officialWebsiteLink": "/podcasts/politicalbreakdown",
"meta": {
"site": "radio",
"source": "kqed",
"order": 5
},
"link": "/podcasts/politicalbreakdown",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/political-breakdown/id1327641087",
"amazon": "https://music.amazon.com/podcasts/e0c2d153-ad36-4c8d-901d-f1da6a724824/political-breakdown",
"npr": "https://www.npr.org/podcasts/572155894/political-breakdown",
"stitcher": "https://www.stitcher.com/podcast/kqed/political-breakdown",
"spotify": "https://open.spotify.com/show/07RVyIjIdk2WDuVehvBMoN",
"rss": "https://ww2.kqed.org/news/tag/political-breakdown/feed/podcast"
}
},
"possible": {
"id": "possible",
"title": "Possible",
"info": "Possible is hosted by entrepreneur Reid Hoffman and writer Aria Finger. Together in Possible, Hoffman and Finger lead enlightening discussions about building a brighter collective future. The show features interviews with visionary guests like Trevor Noah, Sam Altman and Janette Sadik-Khan. Possible paints an optimistic portrait of the world we can create through science, policy, business, art and our shared humanity. It asks: What if everything goes right for once? How can we get there? Each episode also includes a short fiction story generated by advanced AI GPT-4, serving as a thought-provoking springboard to speculate how humanity could leverage technology for good.",
"airtime": "SUN 2pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Possible-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.possible.fm/",
"meta": {
"site": "news",
"source": "Possible"
},
"link": "/radio/program/possible",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/possible/id1677184070",
"spotify": "https://open.spotify.com/show/730YpdUSNlMyPQwNnyjp4k"
}
},
"pri-the-world": {
"id": "pri-the-world",
"title": "PRI's The World: Latest Edition",
"info": "Each weekday, host Marco Werman and his team of producers bring you the world's most interesting stories in an hour of radio that reminds us just how small our planet really is.",
"airtime": "MON-FRI 2pm-3pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-World-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.pri.org/programs/the-world",
"meta": {
"site": "news",
"source": "PRI"
},
"link": "/radio/program/pri-the-world",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/pris-the-world-latest-edition/id278196007?mt=2",
"tuneIn": "https://tunein.com/podcasts/News--Politics-Podcasts/PRIs-The-World-p24/",
"rss": "http://feeds.feedburner.com/pri/theworld"
}
},
"radiolab": {
"id": "radiolab",
"title": "Radiolab",
"info": "A two-time Peabody Award-winner, Radiolab is an investigation told through sounds and stories, and centered around one big idea. In the Radiolab world, information sounds like music and science and culture collide. Hosted by Jad Abumrad and Robert Krulwich, the show is designed for listeners who demand skepticism, but appreciate wonder. WNYC Studios is the producer of other leading podcasts including Freakonomics Radio, Death, Sex & Money, On the Media and many more.",
"airtime": "SUN 12am-1am, SAT 2pm-3pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/radiolab1400.png",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/radiolab/",
"meta": {
"site": "science",
"source": "WNYC"
},
"link": "/radio/program/radiolab",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/radiolab/id152249110?mt=2",
"tuneIn": "https://tunein.com/radio/RadioLab-p68032/",
"rss": "https://feeds.wnyc.org/radiolab"
}
},
"reveal": {
"id": "reveal",
"title": "Reveal",
"info": "Created by The Center for Investigative Reporting and PRX, Reveal is public radios first one-hour weekly radio show and podcast dedicated to investigative reporting. Credible, fact based and without a partisan agenda, Reveal combines the power and artistry of driveway moment storytelling with data-rich reporting on critically important issues. The result is stories that inform and inspire, arming our listeners with information to right injustices, hold the powerful accountable and improve lives.Reveal is hosted by Al Letson and showcases the award-winning work of CIR and newsrooms large and small across the nation. In a radio and podcast market crowded with choices, Reveal focuses on important and often surprising stories that illuminate the world for our listeners.",
"airtime": "SAT 4pm-5pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/reveal300px.png",
"officialWebsiteLink": "https://www.revealnews.org/episodes/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/reveal",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/reveal/id886009669",
"tuneIn": "https://tunein.com/radio/Reveal-p679597/",
"rss": "http://feeds.revealradio.org/revealpodcast"
}
},
"rightnowish": {
"id": "rightnowish",
"title": "Rightnowish",
"tagline": "Art is where you find it",
"info": "Rightnowish digs into life in the Bay Area right now… ish. Journalist Pendarvis Harshaw takes us to galleries painted on the sides of liquor stores in West Oakland. We'll dance in warehouses in the Bayview, make smoothies with kids in South Berkeley, and listen to classical music in a 1984 Cutlass Supreme in Richmond. Every week, Pen talks to movers and shakers about how the Bay Area shapes what they create, and how they shape the place we call home.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Rightnowish-Podcast-Tile-500x500-1.jpg",
"imageAlt": "KQED Rightnowish with Pendarvis Harshaw",
"officialWebsiteLink": "/podcasts/rightnowish",
"meta": {
"site": "arts",
"source": "kqed",
"order": 16
},
"link": "/podcasts/rightnowish",
"subscribe": {
"npr": "https://www.npr.org/podcasts/721590300/rightnowish",
"rss": "https://ww2.kqed.org/arts/programs/rightnowish/feed/podcast",
"apple": "https://podcasts.apple.com/us/podcast/rightnowish/id1482187648",
"stitcher": "https://www.stitcher.com/podcast/kqed/rightnowish",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkMxMjU5MTY3NDc4",
"spotify": "https://open.spotify.com/show/7kEJuafTzTVan7B78ttz1I"
}
},
"science-friday": {
"id": "science-friday",
"title": "Science Friday",
"info": "Science Friday is a weekly science talk show, broadcast live over public radio stations nationwide. Each week, the show focuses on science topics that are in the news and tries to bring an educated, balanced discussion to bear on the scientific issues at hand. Panels of expert guests join host Ira Flatow, a veteran science journalist, to discuss science and to take questions from listeners during the call-in portion of the program.",
"airtime": "FRI 11am-1pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Science-Friday-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/science-friday",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/science-friday",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=73329284&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Science-Friday-p394/",
"rss": "http://feeds.wnyc.org/science-friday"
}
},
"snap-judgment": {
"id": "snap-judgment",
"title": "Snap Judgment",
"tagline": "Real stories with killer beats",
"info": "The Snap Judgment radio show and podcast mixes real stories with killer beats to produce cinematic, dramatic radio. Snap's musical brand of storytelling dares listeners to see the world through the eyes of another. This is storytelling... with a BEAT!! Snap first aired on public radio stations nationwide in July 2010. Today, Snap Judgment airs on over 450 public radio stations and is brought to the airwaves by KQED & PRX.",
"airtime": "SAT 1pm-2pm, 9pm-10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/05/Snap-Judgment-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Snap Judgment",
"officialWebsiteLink": "https://snapjudgment.org",
"meta": {
"site": "arts",
"source": "kqed",
"order": 4
},
"link": "https://snapjudgment.org",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/snap-judgment/id283657561",
"npr": "https://www.npr.org/podcasts/449018144/snap-judgment",
"stitcher": "https://www.pandora.com/podcast/snap-judgment/PC:241?source=stitcher-sunset",
"spotify": "https://open.spotify.com/show/3Cct7ZWmxHNAtLgBTqjC5v",
"rss": "https://snap.feed.snapjudgment.org/"
}
},
"soldout": {
"id": "soldout",
"title": "SOLD OUT: Rethinking Housing in America",
"tagline": "A new future for housing",
"info": "Sold Out: Rethinking Housing in America",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Sold-Out-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Sold Out: Rethinking Housing in America",
"officialWebsiteLink": "/podcasts/soldout",
"meta": {
"site": "news",
"source": "kqed",
"order": 13
},
"link": "/podcasts/soldout",
"subscribe": {
"npr": "https://www.npr.org/podcasts/911586047/s-o-l-d-o-u-t-a-new-future-for-housing",
"apple": "https://podcasts.apple.com/us/podcast/introducing-sold-out-rethinking-housing-in-america/id1531354937",
"rss": "https://feeds.megaphone.fm/soldout",
"spotify": "https://open.spotify.com/show/38dTBSk2ISFoPiyYNoKn1X",
"stitcher": "https://www.stitcher.com/podcast/kqed/sold-out-rethinking-housing-in-america",
"tunein": "https://tunein.com/radio/SOLD-OUT-Rethinking-Housing-in-America-p1365871/"
}
},
"spooked": {
"id": "spooked",
"title": "Spooked",
"tagline": "True-life supernatural stories",
"info": "",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/10/Spooked-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Spooked",
"officialWebsiteLink": "https://spookedpodcast.org/",
"meta": {
"site": "news",
"source": "kqed",
"order": 7
},
"link": "https://spookedpodcast.org/",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/spooked/id1279361017",
"npr": "https://www.npr.org/podcasts/549547848/snap-judgment-presents-spooked",
"spotify": "https://open.spotify.com/show/76571Rfl3m7PLJQZKQIGCT",
"rss": "https://feeds.simplecast.com/TBotaapn"
}
},
"tech-nation": {
"id": "tech-nation",
"title": "Tech Nation Radio Podcast",
"info": "Tech Nation is a weekly public radio program, hosted by Dr. Moira Gunn. Founded in 1993, it has grown from a simple interview show to a multi-faceted production, featuring conversations with noted technology and science leaders, and a weekly science and technology-related commentary.",
"airtime": "FRI 10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Tech-Nation-Radio-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "http://technation.podomatic.com/",
"meta": {
"site": "science",
"source": "Tech Nation Media"
},
"link": "/radio/program/tech-nation",
"subscribe": {
"rss": "https://technation.podomatic.com/rss2.xml"
}
},
"ted-radio-hour": {
"id": "ted-radio-hour",
"title": "TED Radio Hour",
"info": "The TED Radio Hour is a journey through fascinating ideas, astonishing inventions, fresh approaches to old problems, and new ways to think and create.",
"airtime": "SUN 3pm-4pm, SAT 10pm-11pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/tedRadioHour.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/ted-radio-hour/?showDate=2018-06-22",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/ted-radio-hour",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/8vsS",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=523121474&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/TED-Radio-Hour-p418021/",
"rss": "https://feeds.npr.org/510298/podcast.xml"
}
},
"thebay": {
"id": "thebay",
"title": "The Bay",
"tagline": "Local news to keep you rooted",
"info": "Host Devin Katayama walks you through the biggest story of the day with reporters and newsmakers.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Bay-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Bay",
"officialWebsiteLink": "/podcasts/thebay",
"meta": {
"site": "radio",
"source": "kqed",
"order": 2
},
"link": "/podcasts/thebay",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-bay/id1350043452",
"amazon": "https://music.amazon.com/podcasts/d800ea4c-7a2c-42f2-b861-edaf78a5db0b/the-bay",
"npr": "https://www.npr.org/podcasts/586725995/the-bay",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-bay",
"spotify": "https://open.spotify.com/show/4BIKBKIujizLHlIlBNaAqQ",
"rss": "https://feeds.megaphone.fm/KQINC8259786327"
}
},
"thelatest": {
"id": "thelatest",
"title": "The Latest",
"tagline": "Trusted local news in real time",
"info": "",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/05/The-Latest-2025-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Latest",
"officialWebsiteLink": "/thelatest",
"meta": {
"site": "news",
"source": "kqed",
"order": 6
},
"link": "/thelatest",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-latest-from-kqed/id1197721799",
"npr": "https://www.npr.org/podcasts/1257949365/the-latest-from-k-q-e-d",
"spotify": "https://open.spotify.com/show/5KIIXMgM9GTi5AepwOYvIZ?si=bd3053fec7244dba",
"rss": "https://feeds.megaphone.fm/KQINC9137121918"
}
},
"theleap": {
"id": "theleap",
"title": "The Leap",
"tagline": "What if you closed your eyes, and jumped?",
"info": "Stories about people making dramatic, risky changes, told by award-winning public radio reporter Judy Campbell.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Leap-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Leap",
"officialWebsiteLink": "/podcasts/theleap",
"meta": {
"site": "news",
"source": "kqed",
"order": 17
},
"link": "/podcasts/theleap",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-leap/id1046668171",
"npr": "https://www.npr.org/podcasts/447248267/the-leap",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-leap",
"spotify": "https://open.spotify.com/show/3sSlVHHzU0ytLwuGs1SD1U",
"rss": "https://ww2.kqed.org/news/programs/the-leap/feed/podcast"
}
},
"the-moth-radio-hour": {
"id": "the-moth-radio-hour",
"title": "The Moth Radio Hour",
"info": "Since its launch in 1997, The Moth has presented thousands of true stories, told live and without notes, to standing-room-only crowds worldwide. Moth storytellers stand alone, under a spotlight, with only a microphone and a roomful of strangers. The storyteller and the audience embark on a high-wire act of shared experience which is both terrifying and exhilarating. Since 2008, The Moth podcast has featured many of our favorite stories told live on Moth stages around the country. For information on all of our programs and live events, visit themoth.org.",
"airtime": "SAT 8pm-9pm and SUN 11am-12pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/theMoth.jpg",
"officialWebsiteLink": "https://themoth.org/",
"meta": {
"site": "arts",
"source": "prx"
},
"link": "/radio/program/the-moth-radio-hour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/the-moth-podcast/id275699983?mt=2",
"tuneIn": "https://tunein.com/radio/The-Moth-p273888/",
"rss": "http://feeds.themoth.org/themothpodcast"
}
},
"the-new-yorker-radio-hour": {
"id": "the-new-yorker-radio-hour",
"title": "The New Yorker Radio Hour",
"info": "The New Yorker Radio Hour is a weekly program presented by the magazine's editor, David Remnick, and produced by WNYC Studios and The New Yorker. Each episode features a diverse mix of interviews, profiles, storytelling, and an occasional burst of humor inspired by the magazine, and shaped by its writers, artists, and editors. This isn't a radio version of a magazine, but something all its own, reflecting the rich possibilities of audio storytelling and conversation. Theme music for the show was composed and performed by Merrill Garbus of tUnE-YArDs.",
"airtime": "SAT 10am-11am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-New-Yorker-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/tnyradiohour",
"meta": {
"site": "arts",
"source": "WNYC"
},
"link": "/radio/program/the-new-yorker-radio-hour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/id1050430296",
"tuneIn": "https://tunein.com/podcasts/WNYC-Podcasts/New-Yorker-Radio-Hour-p803804/",
"rss": "https://feeds.feedburner.com/newyorkerradiohour"
}
},
"the-sam-sanders-show": {
"id": "the-sam-sanders-show",
"title": "The Sam Sanders Show",
"info": "One of public radio's most dynamic voices, Sam Sanders helped launch The NPR Politics Podcast and hosted NPR's hit show It's Been A Minute. Now, the award-winning host returns with something brand new, The Sam Sanders Show. Every week, Sam Sanders and friends dig into the culture that shapes our lives: what's driving the biggest trends, how artists really think, and even the memes you can't stop scrolling past. Sam is beloved for his way of unpacking the world and bringing you up close to fresh currents and engaging conversations. The Sam Sanders Show is smart, funny and always a good time.",
"airtime": "FRI 12-1pm AND SAT 11am-12pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/11/The-Sam-Sanders-Show-Podcast-Tile-400x400-1.jpg",
"officialWebsiteLink": "https://www.kcrw.com/shows/the-sam-sanders-show/latest",
"meta": {
"site": "arts",
"source": "KCRW"
},
"link": "https://www.kcrw.com/shows/the-sam-sanders-show/latest",
"subscribe": {
"rss": "https://feed.cdnstream1.com/zjb/feed/download/ac/28/59/ac28594c-e1d0-4231-8728-61865cdc80e8.xml"
}
},
"the-splendid-table": {
"id": "the-splendid-table",
"title": "The Splendid Table",
"info": "\u003cem>The Splendid Table\u003c/em> hosts our nation's conversations about cooking, sustainability and food culture.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Splendid-Table-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.splendidtable.org/",
"airtime": "SUN 10-11 pm",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/the-splendid-table"
},
"this-american-life": {
"id": "this-american-life",
"title": "This American Life",
"info": "This American Life is a weekly public radio show, heard by 2.2 million people on more than 500 stations. Another 2.5 million people download the weekly podcast. It is hosted by Ira Glass, produced in collaboration with Chicago Public Media, delivered to stations by PRX The Public Radio Exchange, and has won all of the major broadcasting awards.",
"airtime": "SAT 12pm-1pm, 7pm-8pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/thisAmericanLife.png",
"officialWebsiteLink": "https://www.thisamericanlife.org/",
"meta": {
"site": "news",
"source": "wbez"
},
"link": "/radio/program/this-american-life",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=201671138&at=11l79Y&ct=nprdirectory",
"rss": "https://www.thisamericanlife.org/podcast/rss.xml"
}
},
"tinydeskradio": {
"id": "tinydeskradio",
"title": "Tiny Desk Radio",
"info": "We're bringing the best of Tiny Desk to the airwaves, only on public radio.",
"airtime": "SUN 8pm and SAT 9pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/04/300x300-For-Member-Station-Logo-Tiny-Desk-Radio-@2x.png",
"officialWebsiteLink": "https://www.npr.org/series/g-s1-52030/tiny-desk-radio",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/tinydeskradio",
"subscribe": {
"rss": "https://feeds.npr.org/g-s1-52030/rss.xml"
}
},
"wait-wait-dont-tell-me": {
"id": "wait-wait-dont-tell-me",
"title": "Wait Wait... Don't Tell Me!",
"info": "Peter Sagal and Bill Kurtis host the weekly NPR News quiz show alongside some of the best and brightest news and entertainment personalities.",
"airtime": "SUN 10am-11am, SAT 11am-12pm, SAT 6pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Wait-Wait-Podcast-Tile-300x300-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/wait-wait-dont-tell-me/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/wait-wait-dont-tell-me",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/Xogv",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=121493804&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Wait-Wait-Dont-Tell-Me-p46/",
"rss": "https://feeds.npr.org/344098539/podcast.xml"
}
},
"weekend-edition-saturday": {
"id": "weekend-edition-saturday",
"title": "Weekend Edition Saturday",
"info": "Weekend Edition Saturday wraps up the week's news and offers a mix of analysis and features on a wide range of topics, including arts, sports, entertainment, and human interest stories. The two-hour program is hosted by NPR's Peabody Award-winning Scott Simon.",
"airtime": "SAT 5am-10am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Weekend-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/weekend-edition-saturday/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/weekend-edition-saturday"
},
"weekend-edition-sunday": {
"id": "weekend-edition-sunday",
"title": "Weekend Edition Sunday",
"info": "Weekend Edition Sunday features interviews with newsmakers, artists, scientists, politicians, musicians, writers, theologians and historians. The program has covered news events from Nelson Mandela's 1990 release from a South African prison to the capture of Saddam Hussein.",
"airtime": "SUN 5am-10am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Weekend-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/weekend-edition-sunday/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/weekend-edition-sunday"
}
},
"racesReducer": {},
"racesGenElectionReducer": {},
"racesGenElection2026Reducer": {},
"radioSchedulesReducer": {},
"listsReducer": {
"posts/futureofyou?category=hopehype": {
"isFetching": false,
"latestQuery": {
"from": 288,
"size": 12
},
"vitalsOnly": false,
"totalRequested": 4,
"isLoading": false,
"isLoadingMore": true,
"total": {
"value": 292,
"relation": "eq"
},
"items": [
"futureofyou_2703",
"futureofyou_2981",
"futureofyou_2853",
"futureofyou_839"
],
"complete": true
}
},
"recallGuideReducer": {
"intros": {},
"policy": {},
"candidates": {}
},
"savedArticleReducer": {
"articles": [],
"status": {}
},
"newslettersReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"newsletters": {},
"isSubscribing": false,
"isUnsubscribing": false,
"subscribedNewsletters": {}
},
"termsReducer": {
"about": {
"name": "About",
"type": "terms",
"id": "about",
"slug": "about",
"link": "/about",
"taxonomy": "site"
},
"arts": {
"name": "Arts & Culture",
"grouping": [
"arts",
"pop",
"trulyca"
],
"description": "KQED Arts provides daily in-depth coverage of the Bay Area's music, art, film, performing arts, literature and arts news, as well as cultural commentary and criticism.",
"type": "terms",
"id": "arts",
"slug": "arts",
"link": "/arts",
"taxonomy": "site"
},
"artschool": {
"name": "Art School",
"parent": "arts",
"type": "terms",
"id": "artschool",
"slug": "artschool",
"link": "/artschool",
"taxonomy": "site"
},
"bayareabites": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"parent": "food",
"type": "terms",
"id": "bayareabites",
"slug": "bayareabites",
"link": "/food",
"taxonomy": "site"
},
"bayareahiphop": {
"name": "Bay Area Hiphop",
"type": "terms",
"id": "bayareahiphop",
"slug": "bayareahiphop",
"link": "/bayareahiphop",
"taxonomy": "site"
},
"campaign21": {
"name": "Campaign 21",
"type": "terms",
"id": "campaign21",
"slug": "campaign21",
"link": "/campaign21",
"taxonomy": "site"
},
"careers": {
"name": "Careers",
"type": "terms",
"id": "careers",
"slug": "careers",
"link": "/careers",
"taxonomy": "site"
},
"checkplease": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"parent": "food",
"type": "terms",
"id": "checkplease",
"slug": "checkplease",
"link": "/food",
"taxonomy": "site"
},
"education": {
"name": "Education",
"grouping": [
"education"
],
"type": "terms",
"id": "education",
"slug": "education",
"link": "/education",
"taxonomy": "site"
},
"elections": {
"name": "Elections",
"type": "terms",
"id": "elections",
"slug": "elections",
"link": "/elections",
"taxonomy": "site"
},
"events": {
"name": "Events",
"type": "terms",
"id": "events",
"slug": "events",
"link": "/events",
"taxonomy": "site"
},
"event": {
"name": "Event",
"alias": "events",
"type": "terms",
"id": "event",
"slug": "event",
"link": "/event",
"taxonomy": "site"
},
"filmschoolshorts": {
"name": "Film School Shorts",
"type": "terms",
"id": "filmschoolshorts",
"slug": "filmschoolshorts",
"link": "/filmschoolshorts",
"taxonomy": "site"
},
"food": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"type": "terms",
"id": "food",
"slug": "food",
"link": "/food",
"taxonomy": "site"
},
"forum": {
"name": "Forum",
"relatedContentQuery": "posts/forum?",
"parent": "news",
"type": "terms",
"id": "forum",
"slug": "forum",
"link": "/forum",
"taxonomy": "site"
},
"futureofyou": {
"name": "Future of You",
"grouping": [
"science",
"futureofyou"
],
"parent": "science",
"type": "terms",
"id": "futureofyou",
"slug": "futureofyou",
"link": "/futureofyou",
"taxonomy": "site"
},
"jpepinheart": {
"name": "KQED food",
"relatedContentQuery": "posts/food,bayareabites,checkplease",
"parent": "food",
"type": "terms",
"id": "jpepinheart",
"slug": "jpepinheart",
"link": "/food",
"taxonomy": "site"
},
"liveblog": {
"name": "Live Blog",
"type": "terms",
"id": "liveblog",
"slug": "liveblog",
"link": "/liveblog",
"taxonomy": "site"
},
"livetv": {
"name": "Live TV",
"parent": "tv",
"type": "terms",
"id": "livetv",
"slug": "livetv",
"link": "/livetv",
"taxonomy": "site"
},
"lowdown": {
"name": "The Lowdown",
"relatedContentQuery": "posts/lowdown?",
"parent": "news",
"type": "terms",
"id": "lowdown",
"slug": "lowdown",
"link": "/lowdown",
"taxonomy": "site"
},
"mindshift": {
"name": "Mindshift",
"parent": "news",
"description": "MindShift explores the future of education by highlighting the innovative – and sometimes counterintuitive – ways educators and parents are helping all children succeed.",
"type": "terms",
"id": "mindshift",
"slug": "mindshift",
"link": "/mindshift",
"taxonomy": "site"
},
"news": {
"name": "News",
"grouping": [
"news",
"forum"
],
"type": "terms",
"id": "news",
"slug": "news",
"link": "/news",
"taxonomy": "site"
},
"newsletters": {
"name": "newsletters",
"type": "terms",
"id": "newsletters",
"slug": "newsletters",
"link": "/newsletters",
"taxonomy": "site"
},
"perspectives": {
"name": "Perspectives",
"parent": "radio",
"type": "terms",
"id": "perspectives",
"slug": "perspectives",
"link": "/perspectives",
"taxonomy": "site"
},
"podcasts": {
"name": "Podcasts",
"type": "terms",
"id": "podcasts",
"slug": "podcasts",
"link": "/podcasts",
"taxonomy": "site"
},
"pop": {
"name": "Pop",
"parent": "arts",
"type": "terms",
"id": "pop",
"slug": "pop",
"link": "/pop",
"taxonomy": "site"
},
"pressroom": {
"name": "Pressroom",
"type": "terms",
"id": "pressroom",
"slug": "pressroom",
"link": "/pressroom",
"taxonomy": "site"
},
"quest": {
"name": "Quest",
"parent": "science",
"type": "terms",
"id": "quest",
"slug": "quest",
"link": "/quest",
"taxonomy": "site"
},
"radio": {
"name": "Radio",
"grouping": [
"forum",
"perspectives"
],
"description": "Listen to KQED Public Radio – home of Forum and The California Report – on 88.5 FM in San Francisco, 89.3 FM in Sacramento, 88.3 FM in Santa Rosa and 88.1 FM in Martinez.",
"type": "terms",
"id": "radio",
"slug": "radio",
"link": "/radio",
"taxonomy": "site"
},
"root": {
"name": "KQED",
"image": "https://ww2.kqed.org/app/uploads/2020/02/KQED-OG-Image@1x.png",
"imageWidth": 1200,
"imageHeight": 630,
"headData": {
"title": "KQED | News, Radio, Podcasts, TV | Public Media for Northern California",
"description": "KQED provides public radio, television, and independent reporting on issues that matter to the Bay Area. We’re the NPR and PBS member station for Northern California."
},
"type": "terms",
"id": "root",
"slug": "root",
"link": "/root",
"taxonomy": "site"
},
"science": {
"name": "Science",
"grouping": [
"science",
"futureofyou"
],
"description": "KQED Science brings you award-winning science and environment coverage from the Bay Area and beyond.",
"type": "terms",
"id": "science",
"slug": "science",
"link": "/science",
"taxonomy": "site"
},
"stateofhealth": {
"name": "State of Health",
"parent": "science",
"type": "terms",
"id": "stateofhealth",
"slug": "stateofhealth",
"link": "/stateofhealth",
"taxonomy": "site"
},
"support": {
"name": "Support",
"type": "terms",
"id": "support",
"slug": "support",
"link": "/support",
"taxonomy": "site"
},
"thedolist": {
"name": "The Do List",
"parent": "arts",
"type": "terms",
"id": "thedolist",
"slug": "thedolist",
"link": "/thedolist",
"taxonomy": "site"
},
"trulyca": {
"name": "Truly CA",
"grouping": [
"arts",
"pop",
"trulyca"
],
"parent": "arts",
"type": "terms",
"id": "trulyca",
"slug": "trulyca",
"link": "/trulyca",
"taxonomy": "site"
},
"tv": {
"name": "TV",
"type": "terms",
"id": "tv",
"slug": "tv",
"link": "/tv",
"taxonomy": "site"
},
"voterguide": {
"name": "Voter Guide",
"parent": "elections",
"alias": "elections",
"type": "terms",
"id": "voterguide",
"slug": "voterguide",
"link": "/voterguide",
"taxonomy": "site"
},
"guiaelectoral": {
"name": "Guia Electoral",
"parent": "elections",
"alias": "elections",
"type": "terms",
"id": "guiaelectoral",
"slug": "guiaelectoral",
"link": "/guiaelectoral",
"taxonomy": "site"
},
"futureofyou_category_hopehype": {
"isLoading": true
},
"futureofyou_1062": {
"type": "terms",
"id": "futureofyou_1062",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1062",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Hope/Hype",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Hope/Hype Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1062,
"slug": "hopehype",
"isLoading": false,
"link": "/futureofyou/category/hopehype"
},
"futureofyou_172": {
"type": "terms",
"id": "futureofyou_172",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "172",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Contributor",
"description": null,
"taxonomy": "series",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Contributor Archives | KQED Arts",
"ogDescription": null
},
"ttid": 172,
"slug": "contributor",
"isLoading": false,
"link": "/futureofyou/series/contributor"
},
"futureofyou_219": {
"type": "terms",
"id": "futureofyou_219",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "219",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Women's Health",
"description": null,
"taxonomy": "series",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Women's Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 219,
"slug": "womens-health",
"isLoading": false,
"link": "/futureofyou/series/womens-health"
},
"futureofyou_1060": {
"type": "terms",
"id": "futureofyou_1060",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1060",
"found": true
},
"relationships": {},
"featImg": null,
"name": "DIY Health",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "DIY Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1060,
"slug": "diy-health",
"isLoading": false,
"link": "/futureofyou/category/diy-health"
},
"futureofyou_235": {
"type": "terms",
"id": "futureofyou_235",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "235",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Apple",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Apple Archives | KQED Arts",
"ogDescription": null
},
"ttid": 235,
"slug": "apple",
"isLoading": false,
"link": "/futureofyou/tag/apple"
},
"futureofyou_264": {
"type": "terms",
"id": "futureofyou_264",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "264",
"found": true
},
"relationships": {},
"featImg": null,
"name": "breast cancer",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "breast cancer Archives | KQED Arts",
"ogDescription": null
},
"ttid": 264,
"slug": "breast-cancer",
"isLoading": false,
"link": "/futureofyou/tag/breast-cancer"
},
"futureofyou_103": {
"type": "terms",
"id": "futureofyou_103",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "103",
"found": true
},
"relationships": {},
"featImg": null,
"name": "cancer",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "cancer Archives | KQED Arts",
"ogDescription": null
},
"ttid": 103,
"slug": "cancer",
"isLoading": false,
"link": "/futureofyou/tag/cancer"
},
"futureofyou_175": {
"type": "terms",
"id": "futureofyou_175",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "175",
"found": true
},
"relationships": {},
"featImg": null,
"name": "contributor",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "contributor Archives | KQED Arts",
"ogDescription": null
},
"ttid": 175,
"slug": "contributor",
"isLoading": false,
"link": "/futureofyou/tag/contributor"
},
"futureofyou_34": {
"type": "terms",
"id": "futureofyou_34",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "34",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Future of You",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Future of You Archives | KQED Arts",
"ogDescription": null
},
"ttid": 34,
"slug": "future-of-you",
"isLoading": false,
"link": "/futureofyou/tag/future-of-you"
},
"futureofyou_273": {
"type": "terms",
"id": "futureofyou_273",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "273",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Gabrielle Guthrie",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Gabrielle Guthrie Archives | KQED Arts",
"ogDescription": null
},
"ttid": 273,
"slug": "gabrielle-guthrie",
"isLoading": false,
"link": "/futureofyou/tag/gabrielle-guthrie"
},
"futureofyou_80": {
"type": "terms",
"id": "futureofyou_80",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "80",
"found": true
},
"relationships": {},
"featImg": null,
"name": "kqedscience",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "kqedscience Archives | KQED Arts",
"ogDescription": null
},
"ttid": 80,
"slug": "kqedscience",
"isLoading": false,
"link": "/futureofyou/tag/kqedscience"
},
"futureofyou_269": {
"type": "terms",
"id": "futureofyou_269",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "269",
"found": true
},
"relationships": {},
"featImg": null,
"name": "researchkit",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "researchkit Archives | KQED Arts",
"ogDescription": null
},
"ttid": 269,
"slug": "researchkit",
"isLoading": false,
"link": "/futureofyou/tag/researchkit"
},
"futureofyou_276": {
"type": "terms",
"id": "futureofyou_276",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "276",
"found": true
},
"relationships": {},
"featImg": null,
"name": "screening",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "screening Archives | KQED Arts",
"ogDescription": null
},
"ttid": 276,
"slug": "screening",
"isLoading": false,
"link": "/futureofyou/tag/screening"
},
"futureofyou_275": {
"type": "terms",
"id": "futureofyou_275",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "275",
"found": true
},
"relationships": {},
"featImg": null,
"name": "women's health",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "women's health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 275,
"slug": "womens-health",
"isLoading": false,
"link": "/futureofyou/tag/womens-health"
},
"futureofyou_135": {
"type": "terms",
"id": "futureofyou_135",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "135",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Q&A",
"description": null,
"taxonomy": "series",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Q&A Archives | KQED Arts",
"ogDescription": null
},
"ttid": 135,
"slug": "qa",
"isLoading": false,
"link": "/futureofyou/series/qa"
},
"futureofyou_316": {
"type": "terms",
"id": "futureofyou_316",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "316",
"found": true
},
"relationships": {},
"featImg": null,
"name": "D-Rev",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "D-Rev Archives | KQED Arts",
"ogDescription": null
},
"ttid": 316,
"slug": "d-rev",
"isLoading": false,
"link": "/futureofyou/tag/d-rev"
},
"futureofyou_320": {
"type": "terms",
"id": "futureofyou_320",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "320",
"found": true
},
"relationships": {},
"featImg": null,
"name": "developing countries",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "developing countries Archives | KQED Arts",
"ogDescription": null
},
"ttid": 320,
"slug": "developing-countries",
"isLoading": false,
"link": "/futureofyou/tag/developing-countries"
},
"futureofyou_322": {
"type": "terms",
"id": "futureofyou_322",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "322",
"found": true
},
"relationships": {},
"featImg": null,
"name": "jaundice",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "jaundice Archives | KQED Arts",
"ogDescription": null
},
"ttid": 322,
"slug": "jaundice",
"isLoading": false,
"link": "/futureofyou/tag/jaundice"
},
"futureofyou_317": {
"type": "terms",
"id": "futureofyou_317",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "317",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Krista Donaldson",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Krista Donaldson Archives | KQED Arts",
"ogDescription": null
},
"ttid": 317,
"slug": "krista-donaldson",
"isLoading": false,
"link": "/futureofyou/tag/krista-donaldson"
},
"futureofyou_321": {
"type": "terms",
"id": "futureofyou_321",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "321",
"found": true
},
"relationships": {},
"featImg": null,
"name": "low income",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "low income Archives | KQED Arts",
"ogDescription": null
},
"ttid": 321,
"slug": "low-income",
"isLoading": false,
"link": "/futureofyou/tag/low-income"
},
"futureofyou_319": {
"type": "terms",
"id": "futureofyou_319",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "319",
"found": true
},
"relationships": {},
"featImg": null,
"name": "medical device",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "medical device Archives | KQED Arts",
"ogDescription": null
},
"ttid": 319,
"slug": "medical-device",
"isLoading": false,
"link": "/futureofyou/tag/medical-device"
},
"futureofyou_323": {
"type": "terms",
"id": "futureofyou_323",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "323",
"found": true
},
"relationships": {},
"featImg": null,
"name": "prosthetic",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "prosthetic Archives | KQED Arts",
"ogDescription": null
},
"ttid": 323,
"slug": "prosthetic",
"isLoading": false,
"link": "/futureofyou/tag/prosthetic"
},
"futureofyou_318": {
"type": "terms",
"id": "futureofyou_318",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "318",
"found": true
},
"relationships": {},
"featImg": null,
"name": "TED",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "TED Archives | KQED Arts",
"ogDescription": null
},
"ttid": 318,
"slug": "ted",
"isLoading": false,
"link": "/futureofyou/tag/ted"
},
"futureofyou_1064": {
"type": "terms",
"id": "futureofyou_1064",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1064",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Your Genes",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Your Genes Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1064,
"slug": "your-genes",
"isLoading": false,
"link": "/futureofyou/category/your-genes"
},
"futureofyou_17": {
"type": "terms",
"id": "futureofyou_17",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "17",
"found": true
},
"relationships": {},
"featImg": null,
"name": "DNA",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "DNA Archives | KQED Arts",
"ogDescription": null
},
"ttid": 17,
"slug": "dna",
"isLoading": false,
"link": "/futureofyou/tag/dna"
},
"futureofyou_292": {
"type": "terms",
"id": "futureofyou_292",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "292",
"found": true
},
"relationships": {},
"featImg": null,
"name": "eugenics",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "eugenics Archives | KQED Arts",
"ogDescription": null
},
"ttid": 292,
"slug": "eugenics",
"isLoading": false,
"link": "/futureofyou/tag/eugenics"
},
"futureofyou_138": {
"type": "terms",
"id": "futureofyou_138",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "138",
"found": true
},
"relationships": {},
"featImg": null,
"name": "futureofyou",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "futureofyou Archives | KQED Arts",
"ogDescription": null
},
"ttid": 138,
"slug": "futureofyou",
"isLoading": false,
"link": "/futureofyou/tag/futureofyou"
},
"futureofyou_295": {
"type": "terms",
"id": "futureofyou_295",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "295",
"found": true
},
"relationships": {},
"featImg": null,
"name": "gene editing",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "gene editing Archives | KQED Arts",
"ogDescription": null
},
"ttid": 295,
"slug": "gene-editing",
"isLoading": false,
"link": "/futureofyou/tag/gene-editing"
},
"futureofyou_19": {
"type": "terms",
"id": "futureofyou_19",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "19",
"found": true
},
"relationships": {},
"featImg": null,
"name": "gene sequencing",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "gene sequencing Archives | KQED Arts",
"ogDescription": null
},
"ttid": 19,
"slug": "gene-sequencing",
"isLoading": false,
"link": "/futureofyou/tag/gene-sequencing"
},
"futureofyou_294": {
"type": "terms",
"id": "futureofyou_294",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "294",
"found": true
},
"relationships": {},
"featImg": null,
"name": "research",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "research Archives | KQED Arts",
"ogDescription": null
},
"ttid": 294,
"slug": "research",
"isLoading": false,
"link": "/futureofyou/tag/research"
},
"futureofyou_271": {
"type": "terms",
"id": "futureofyou_271",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "271",
"found": true
},
"relationships": {},
"featImg": null,
"name": "science",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "science Archives | KQED Arts",
"ogDescription": null
},
"ttid": 271,
"slug": "science",
"isLoading": false,
"link": "/futureofyou/tag/science"
},
"futureofyou_126": {
"type": "terms",
"id": "futureofyou_126",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "126",
"found": true
},
"relationships": {},
"featImg": null,
"name": "colorblindness",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "colorblindness Archives | KQED Arts",
"ogDescription": null
},
"ttid": 126,
"slug": "colorblindness",
"isLoading": false,
"link": "/futureofyou/tag/colorblindness"
},
"futureofyou_125": {
"type": "terms",
"id": "futureofyou_125",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "125",
"found": true
},
"relationships": {},
"featImg": null,
"name": "NPR",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "NPR Archives | KQED Arts",
"ogDescription": null
},
"ttid": 125,
"slug": "npr",
"isLoading": false,
"link": "/futureofyou/tag/npr"
},
"futureofyou_127": {
"type": "terms",
"id": "futureofyou_127",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "127",
"found": true
},
"relationships": {},
"featImg": null,
"name": "University of Washington",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "University of Washington Archives | KQED Arts",
"ogDescription": null
},
"ttid": 127,
"slug": "university-of-washington",
"isLoading": false,
"link": "/futureofyou/tag/university-of-washington"
}
},
"userPermissionsReducer": {
"wpLoggedIn": false
},
"eventsReducer": {},
"fssReducer": {},
"tvDailyScheduleReducer": {},
"tvWeeklyScheduleReducer": {},
"tvPrimetimeScheduleReducer": {},
"tvMonthlyScheduleReducer": {},
"userAccountReducer": {
"user": {
"email": null,
"emailStatus": "EMAIL_UNVALIDATED",
"loggedStatus": "LOGGED_OUT",
"loggingChecked": false,
"articles": [],
"firstName": null,
"lastName": null,
"phoneNumber": null,
"fetchingMembership": false,
"membershipError": false,
"memberships": [
{
"id": null,
"startDate": null,
"firstName": null,
"lastName": null,
"familyNumber": null,
"memberNumber": null,
"memberSince": null,
"expirationDate": null,
"pfsEligible": false,
"isSustaining": false,
"membershipLevel": "Prospect",
"membershipStatus": "Non Member",
"lastGiftDate": null,
"renewalDate": null,
"lastDonationAmount": null
}
]
},
"authModal": {
"isOpen": false,
"view": "LANDING_VIEW"
},
"error": null
},
"youthMediaReducer": {},
"checkPleaseReducer": {
"filterData": {
"region": {
"key": "Restaurant Region",
"filters": [
"Any Region"
]
},
"cuisine": {
"key": "Restaurant Cuisine",
"filters": [
"Any Cuisine"
]
}
},
"restaurantDataById": {},
"restaurantIdsSorted": [],
"error": null
},
"userAgentReducer": {
"userAgent": "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)",
"isBot": true
}
}
